# 13 Female

**Page range:** 306â€“517

```text
13
Female
UNITED STATES OF
AMERICA
Spontaneous
Healthcare professional
Pneumonia
Grade 4
185
(1) PRALSETINIB (S)

(2) CALCITRIOL (C)
Drug interrupted
Positive
NA
 Recovering/Resolving
3067477
60
Female
GERMANY
Spontaneous
Non-Healthcare
professional
Pneumocystis jirovecii
pneumonia
Grade 4
80
(1) PRALSETINIB (S)
NR
Unkown
N/A
Recovered/Resolved
3205767
Not reported
Not reported
CHINA
Non-Interventional
Study/Program
Non-Healthcare
professional
Pneumonia
Grade 4
195
(1) PRALSETINIB (S)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing
2708994
63
Male
Sepsis

Pneumonia
835

833
(1) PRALSETINIB (S)
N/A

Doseinterrupted

AER Number
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time to Onset (in
days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
TAIWAN, PROVINCE
OF CHINA
Clinical Study
Healthcare professional
Grade 5

Grade 4
N/A

Positive
N/A

N/A
Fatal

Recovered/Resolved With
Sequelae


77
Drug Safety Report No: 1132062
Appendix 6
Case Listings Reporting Grade 3 Infections from the
Company Safety Database (N=276)

Category B (N=236)
AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2790973
72
Female
FRANCE
Clinical Study
Healthcare
professional
Pyelonephritis
Grade 3
47
(1) PRALSETINIB (S)

(2) METFORMIN (C)

(3) IRBESARTAN (C)

(4) SIMVASTATIN (C)

(5) COLECALCIFEROL (C)

(6) OMEPRAZOLE (C)

(7) PARACETAMOL (C)

(8) TINZAPARIN SODIUM (C)

(9) AMOXICILLIN (C)

(10) NITROFURANTOIN (C)

(11) LEVOFLOXACIN (C)

(12) CEFTRIAXONE SODIUM (C)

(13) NORFLOXACIN (C)

(14) BISOPROLOL (C)

(15) OFLOXACIN (C)

(16) PROMESTRIENE (C)

Dose reduced
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(17) ALFUZOSIN HYDROCHLORIDE (C)

(18) MECILLINAM (C)

(19) RIVAROXABAN (C)

(20) OFLOXACIN (C)
2944253
74
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
64
(1) PRALSETINIB (S)

(2) ALANINE\ARGININE\CALCIUM CHLORIDE\CYSTEINE
HYDROCHLORIDE\GLUCOSE\GLYCINE\HISTIDINE\ISOLE
UCINE\LEUCINE\LYSINE ACETATE\MAGNESIUM
CHLORIDE\METHIONINE\PHENYLALANINE\POTASSIUM
CHLORIDE\POTASSIUM PHOSPHATE
MONOBASIC\PROLINE\SERINE\SODIUM
ACETATE\SODIUM
CHLORIDE\THREONINE\TRYPTOPHAN\VALINE (C)

(3) CHROMIC CHLORIDE\COPPER
SULFATE\MANGANESE SULFATE\ZINC SULFATE (C)

(4) FERROUS SULFATE (C)

(5) PREGABALIN (C)

(6) MAGNESIUM OXIDE (C)

(7) URSODEOXYCHOLIC ACID (C)

(8) ACETYLSALICYLIC ACID (C)

(9) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(10) LACTULOSE (C)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(11) ORNITHINE ASPARTATE (C)

(12) ALANINE\ARGININE\CALCIUM CHLORIDE
DIHYDRATE\FISH OIL\GLUCOSE
MONOHYDRATE\GLYCINE\GLYCINE MAX
OIL\HISTIDINE\ISOLEUCINE\LEUCINE\LYSINE
HYDROCHLORIDE\MAGNESIUM SULFATE
HEPTAHYDRATE\MEDIUM-CHAIN
TRIGLYCERIDES\METHIONINE\OLEA EUROPAEA
OIL\PHENYLALANINE\POTASSIUM
CHLORIDE\PROLINE\SERINE\SODIUM ACETATE
TRIHYDRATE\SODIUM
GLYCEROPHOSPHATE\THREONINE\TRYPTOPHAN\TYRO
SINE\VALINE\ZINC SULFATE HEPTAHYDRATE (C)

(13) CALCIUM POLYSTYRENE SULFONATE (C)

(14) MUPIROCIN (C)

(15) GLYCEROL (C)

(16) POTASSIUM PHOSPHATE MONOBASIC (C)

(17) INSULIN HUMAN (C)

(18) ZOLPIDEM TARTRATE (C)

(19) ALBUMIN HUMAN (C)

(20) FUROSEMIDE (C)

(21) PHENYLEPHRINE HYDROCHLORIDE\TROPICAMIDE
(C)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(22) POLYCARBOPHIL CALCIUM (C)

(23) CHLORPHENAMINE MALEATE (C)

(24) PRUCALOPRIDE SUCCINATE (C)

(25) ARIPIPRAZOLE (C)

(26) CODEINE (C)

(27) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(28) LEVOFLOXACIN (T)

(29) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(30) METHYLPREDNISOLONE SODIUM SUCCINATE (T)

(31) SALBUTAMOL SULFATE (T)

(32) IPRATROPIUM BROMIDE (T)

(33) ACETYLCYSTEINE (T)

(34) OXYGEN (T)

(35) GANCICLOVIR (T)

(36) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(37) METHYLPREDNISOLONE SODIUM SUCCINATE (T)

(38) FLUCONAZOLE (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(39) MEROPENEM (T)

(40) TEICOPLANIN (T)
2951941
72
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Device related
infection

Pleural infection
Grade 3

Grade 3
213

203
(1) PRALSETINIB (S)

(2) FERROUS SULFATE (C)

(3) MAGNESIUM OXIDE (C)

(4) CODEINE (C)

(5) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(6) LEVOTHYROXINE SODIUM (C)

(7) LACTULOSE (C)

(8) FEBUXOSTAT (C)

(9) URSODEOXYCHOLIC ACID (C)

(10) LOPERAMIDE (C)

(11) BENZYDAMINE HYDROCHLORIDE (C)

(12) ZOLPIDEM TARTRATE (C)

(13) CHOLINE ALFOSCERATE (C)

(14) CEFTRIAXONE (C)

(15) ALBUMIN HUMAN (C)

NR

NR
Unknown

Unknown
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(16) FUROSEMIDE (C)

(17) SULFAMETHOXAZOLE\TRIMETHOPRIM (C)

(18) CEFPODOXIME PROXETIL (C)

(19) ERDOSTEINE (C)

(20) PREDNISOLONE (C)

(21) LACTULOSE (C)

(22) PARACETAMOL (C)

(23) PROPACETAMOL (C)

(24) ALANINE\ARGININE\CALCIUM CHLORIDE
DIHYDRATE\FISH OIL\GLUCOSE
MONOHYDRATE\GLYCINE\GLYCINE MAX
OIL\HISTIDINE\ISOLEUCINE\LEUCINE\LYSINE
HYDROCHLORIDE\MAGNESIUM SULFATE
HEPTAHYDRATE\MEDIUM-CHAIN
TRIGLYCERIDES\METHIONINE\OLEA EUROPAEA
OIL\PHENYLALANINE\POTASSIUM
CHLORIDE\PROLINE\SERINE\SODIUM ACETATE
TRIHYDRATE\SODIUM
GLYCEROPHOSPHATE\THREONINE\TRYPTOPHAN\TYRO
SINE\VALINE\ZINC SULFATE HEPTAHYDRATE (C)

(25) TRANEXAMIC ACID (C)

(26) FAMOTIDINE (C)

(27) LEVOTHYROXINE SODIUM (C)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(28) ALANINE\ARGININE\CALCIUM CHLORIDE\FISH
OIL\GLUCOSE MONOHYDRATE\GLYCINE\GLYCINE MAX
SEED OIL\HISTIDINE\ISOLEUCINE\LEUCINE\LYSINE
ACETATE\MAGNESIUM SULFATE\MEDIUM-CHAIN
TRIGLYCERIDES\METHIONINE\OLEA EUROPAEA
OIL\PHENYLALANINE\POTASSIUM
CHLORIDE\PROLINE\SERINE\SODIUM ACETATE\SODIUM
GLYCEROPHOSPHATE\TAURINE\THREONINE\TRYPTOP
HAN\TYROSINE\VALINE\ZINC SULFATE (C)

(29) CHROMIC CHLORIDE\COPPER
SULFATE\MANGANESE SULFATE\ZINC SULFATE (C)

(30) DIOSMECTITE (C)

(31) MEGESTROL ACETATE (C)

(32) CIPROFLOXACIN (C)

(33) FOLIC ACID (C)

(34) COBAMAMIDE (C)

(35) PALONOSETRON HYDROCHLORIDE (C)

(36) APREPITANT (C)

(37) DEXAMETHASONE (C)

(38) PEMETREXED DISODIUM HEMIPENTAHYDRATE (C)

(39) CARBOPLATIN (C)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(40) SODIUM BICARBONATE (C)

(41) VITIS VINIFERA SEED (C)

(42) LOPERAMIDE (C)

(43) CHLORPHENAMINE MALEATE (C)

(44) FILGRASTIM (C)

(45) DIMETHYL 4,4'-
BIPHENYLDICARBOXYLATE\URSODEOXYCHOLIC ACID
(C)

(46) RED BLOOD CELLS (C)

(47) PLATELETS, CONCENTRATED (C)

(48) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(49) LEVOFLOXACIN (T)

(50) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(51) METHYLPREDNISOLONE SODIUM SUCCINATE (T)

(52) TEICOPLANIN (T)

(53) CEFPODOXIME PROXETIL (T)

(54) SODIUM BICARBONATE (T)

(55) CALCIUM POLYSTYRENE SULFONATE (T)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(56) GLUCOSE (T)

(57) INSULIN HUMAN (T)

(58) CALCIUM POLYSTYRENE SULFONATE (T)

(59) CALCIUM POLYSTYRENE SULFONATE (T)

(60) FUROSEMIDE (T)

(61) ALBUMIN HUMAN (T)

(62) SODIUM BICARBONATE (T)

(63) SODIUM CHLORIDE (T)

(64) PARACETAMOL (T)

(65) TAZOBACTAM (T)

(66) FLUCONAZOLE (T)

(67) CASPOFUNGIN ACETATE (T)

(68) TEICOPLANIN (T)

(69) PROPACETAMOL HYDROCHLORIDE (T)

(70) PARACETAMOL (T)

(71) BLOOD PLASMA (T)

(72) OXYGEN (T)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(73) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(74) FLUCONAZOLE (T)

(75) CIPROFLOXACIN (T)
2727438
80
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
182
(1) PRALSETINIB (S)

(2) DEXTROMETHORPHAN
HYDROBROMIDE\GUAIFENESIN (C)

(3) IPRATROPIUM (C)

(4) LORAZEPAM (C)

(5) OMEPRAZOLE (C)

(6) PROCHLORPERAZINE (C)

(7) CAMPHOR\MENTHOL (C)

(8) PARACETAMOL (C)

(9) MEGLUMINE GADOTERATE (C)

(10) IOHEXOL (C)

(11) COLECALCIFEROL (C)

(12) NYSTATIN (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2762461
65
Not reported
CHINA
Spontaneous
Pneumonia
Grade 3
14
(1) PRALSETINIB (S)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional
2765097
73
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Pneumonia
Grade 3
509
(1) PRALSETINIB (S)

(2) CALCIUM CARBONATE (C)

(3) ESTRADIOL (C)

(4) LANSOPRAZOLE (C)

(5) LEVOTHYROXINE (C)

(6) METOPROLOL (C)

(7) NAPROXEN SODIUM (C)

(8) RIVAROXABAN (C)

(9) DOXYCYCLINE HYCLATE (C)

(10) CHLORHEXIDINE (C)

(11) FLECAINIDE (C)

(12) LORATADINE (C)

(13) ACETYLSALICYLIC ACID (C)

(14) CAFFEINE (C)

(15) PARACETAMOL (C)

(16) CHLORHEXIDINE (C)

Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(17) LACTOBACILLUS ACIDOPHILUS (C)

(18) MAGNESIUM HYDROXIDE (C)

(19) COLECALCIFEROL (C)

(20) TRIAMCINOLONE (C)

(21) DICYCLOVERINE (C)

(22) PARACETAMOL (C)

(23) CHLORHEXIDINE (T)

(24) ULOBETASOL (T)

(25) FUROSEMIDE (T)
2798611
48
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
183
(1) PRALSETINIB (S)

(2) LEVOFLOXACIN (T)

(3) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
N/A
N/A
N/A
Not Recovered/Not
Resolved/Ongoing
2798893
70
Male
SPAIN
Clinical Study
Healthcare
professional
Renal
tuberculosis
Grade 3
125
(1) PRALSETINIB (S)

(2) VERAPAMIL HYDROCHLORIDE (C)

(3) ISONIAZID (T)

(4) RIFAMPICIN (T)

(5) PYRAZINAMIDE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(6) ETHAMBUTOL (T)

(7) PREDNISONE (T)
2798895
39
Male
GERMANY
Clinical Study
Healthcare
professional
Pneumocystis
jirovecii
pneumonia
Grade 3
21
(1) PRALSETINIB (S)

(2) BISOPROLOL (C)

(3) AMLODIPINE (C)

(4) RANITIDINE (C)

(5) HYDROCORTISONE (C)

(6) LEVOTHYROXINE (C)

(7) MORPHINE (C)

(8) PREGABALIN (C)

(9) TORASEMIDE (C)

(10) CHLORHEXIDINE
GLUCONATE\MACROGOL\SACCHARIN SODIUM\SODIUM
BICARBONATE\SODIUM EDETATE (C)

(11) TETRACAINE (C)

(12) AMPHOTERICIN B (C)

(13) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(14) TORASEMIDE (T)

Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(15) PREDNISOLONE (T)

(16) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(17) PENTAMIDINE ISETHIONATE (T)

(18) DOXYLAMINE SUCCINATE\FOLIC ACID\PYRIDOXINE
HYDROCHLORIDE (T)
2798919
52
Female
UNITED
KINGDOM
Clinical Study
Healthcare
professional
Tonsillitis
Grade 3
100
(1) PRALSETINIB (S)

(2) APIXABAN (C)

(3) CALCIUM CARBONATE (C)

(4) SENNA SPP. (C)

(5) HYPROMELLOSE (C)

(6) DENOSUMAB (C)

(7) MACROGOL (C)

(8) SEA WATER (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2799041
58
Female
FRANCE
Clinical Study
Healthcare
professional
Pyelonephritis
Grade 3
162
(1) PRALSETINIB (S)

(2) MEROPENEM (T)

(3) FOSFOMYCIN TROMETAMOL (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2799071
59
Female
FRANCE
Pneumonia
Grade 3
196
(1) PRALSETINIB (S)

(2) AMOXICILLIN\CLAVULANATE POTASSIUM (T)
Dose interrupted
Positive
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional

(3) VANCOMYCIN (T)
Recovered/Resolve
d
2799103
73
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
219
(1) PRALSETINIB (S)

(2) GABAPENTIN (C)

(3) LEVOTHYROXINE SODIUM (C)

(4) LORAZEPAM (C)

(5) MACROGOL 3350 (C)

(6) ALENDRONATE SODIUM (C)

(7) BISOPROLOL FUMARATE (C)

(8) LISINOPRIL DIHYDRATE (C)

(9) ASCORBIC ACID\CUPRIC OXIDE\DL-ALPHA
TOCOPHERYL ACETATE\XANTOFYL\ZEAXANTHIN\ZINC
OXIDE (C)

(10) CALCIUM (C)

(11) CEFTAZIDIME (T)

(12) METRONIDAZOLE (T)

(13) PARACETAMOL (T)

(14) ENOXAPARIN SODIUM (T)
NR
Unknown
N/A
Recovered/Resolve
d With Sequelae
2799112
60
Pyelonephritis
Grade 3
41
(1) PRALSETINIB (S)

NR
Unknown

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Female
FRANCE
Clinical Study
Healthcare
professional
(2) HYDROCORTISONE (C)

(3) PARACETAMOL (C)

(4) FLUDROCORTISONE (C)

(5) MANIDIPINE (C)

(6) TINZAPARIN SODIUM (C)

(7) NICARDIPINE HYDROCHLORIDE (C)

(8) NICARDIPINE HYDROCHLORIDE (C)

(9) SODIUM CHLORIDE (C)

(10) OXYCODONE HYDROCHLORIDE (C)

(11) RED BLOOD CELLS (C)

(12) SODIUM POLYSTYRENE SULFONATE (C)

(13) LIDOCAINE (C)

(14) CALCIUM CARBONATE (C)

(15) POTASSIUM (C)

(16) ONDANSETRON (C)

(17) DOMPERIDONE (C)

(18) CALCIUM CHLORIDE (C)

N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(19) PLATELETS, HUMAN BLOOD (C)

(20) GLUCOSE (C)

(21) PIPERACILLIN\TAZOBACTAM (T)

(22) AMOXICILLIN (T)

(23) AMOXICILLIN (T)
2799197
65
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
32
(1) PRALSETINIB (S)

(2) METFORMIN HYDROCHLORIDE (C)

(3) HYDROCHLOROTHIAZIDE\VALSARTAN (C)

(4) LACTULOSE (C)

(5) PSEUDOEPHEDRINE HYDROCHLORIDE (C)

(6) AMMONIUM CHLORIDE\CHLORPHENAMINE
MALEATE\DIHYDROCODEINE
BITARTRATE\METHYLEPHEDRINE HYDROCHLORIDE-DL
(C)

(7) DEXAMETHASONE (C)

(8) MEGESTROL ACETATE (C)

(9) INSULIN HUMAN (C)

(10) POTASSIUM PHOSPHATE MONOBASIC (C)

(11) PROPACETAMOL HYDROCHLORIDE (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(12) PETHIDINE (C)

(13) PETHIDINE HYDROCHLORIDE (T)

(14) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(15) MOXIFLOXACIN HYDROCHLORIDE (T)

(16) AMBROXOL ACEFYLLINATE (T)

(17) AMBROXOL HYDROCHLORIDE (T)

(18) POTASSIUM PHOSPHATE MONOBASIC (T)
2799576
25
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Sepsis

Urinary tract
infection bacterial
Grade 4

Grade 3
843

843
(1) PRALSETINIB (S)

(2) HYDROCHLOROTHIAZIDE (C)

(3) ONDANSETRON (C)

(4) ZINC SULFATE (C)

(5) CARVEDILOL (C)

(6) HYDRALAZINE HYDROCHLORIDE (C)

(7) AMLODIPINE BESILATE (C)

(8) CALCIUM CARBONATE (C)

(9) ESOMEPRAZOLE (C)

(10) TRAMADOL (C)

(11) PARACETAMOL (C)
Dose not changed

Dose not changed
N/A

N/A
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(12) CALCITRIOL (C)

(13) FAMOTIDINE (C)

(14) HYDROCHLOROTHIAZIDE (C)

(15) LACTOBACILLUS ACIDOPHILUS (C)

(16) MAGNESIUM HYDROXIDE (C)

(17) PREDNISONE (C)

(18) LEVOTHYROXINE SODIUM (C)

(19) TAMSULOSIN (C)

(20) SOLIFENACIN SUCCINATE (C)

(21) CEFUROXIME (T)

(22) MEROPENEM (T)

(23) GENTAMICIN (T)

(24) SODIUM CHLORIDE (T)

(25) SOLIFENACIN (T)

(26) TAMSULOSIN (T)

(27) PROMETHAZINE (T)

(28) PARACETAMOL (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(29) CALCITRIOL (T)

(30) FAMOTIDINE (T)

(31) LACTOBACILLUS ACIDOPHILUS (T)

(32) PREDNISONE (T)

(33) HYDRALAZINE (T)

(34) LABETALOL (T)
2799578
26
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Urinary tract
infection

Klebsiella
bacteraemia
Grade 3

Grade 3
865

865
(1) PRALSETINIB (S)

(2) SULFAMETHOXAZOLE\TRIMETHOPRIM (C)
Dose not changed

Dose not changed
N/A

N/A
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d
2799584
52
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia

Sepsis
Grade 3

Grade 3
310

310
(1) PRALSETINIB (S)

(2) ALLOPURINOL (C)

(3) AMLODIPINE BESILATE (C)

(4) SIMETICONE (C)

Dose interrupted

Dose interrupted
Positive

Positive
N/A


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(5) CLOTRIMAZOLE (C)

(6) CLONIDINE (C)

(7) ERGOCALCIFEROL (C)

(8) FLUOXETINE HYDROCHLORIDE (C)

(9) GABAPENTIN (C)

(10) LEVOTHYROXINE SODIUM (C)

(11) LIDOCAINE (C)

(12) LISINOPRIL (C)

(13) LOPERAMIDE HYDROCHLORIDE (C)

(14) LORATADINE (C)

(15) DIPHENHYDRAMINE\LIDOCAINE (C)

(16) MORPHINE SULFATE (C)

(17) MORPHINE SULFATE (C)

(18) ONDANSETRON (C)

(19) MACROGOL 3350 (C)

(20) PROMETHAZINE (C)

(21) SIMETICONE (C)

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(22) TRIAMCINOLONE ACETONIDE (C)

(23) FAMOTIDINE (C)

(24) MUPIROCIN (C)

(25) TRIAMCINOLONE ACETONIDE (C)

(26) ATROPINE SULFATE\DIPHENOXYLATE
HYDROCHLORIDE (C)

(27) MICONAZOLE NITRATE (C)

(28) SALBUTAMOL SULFATE (C)

(29) NYSTATIN (C)

(30) ALPRAZOLAM (C)
2799585
31
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
19
(1) PRALSETINIB (S)

(2) PREDNISONE (C)

(3) AMLODIPINE (C)

(4) PARACETAMOL (C)

(5) CALCIUM ASCORBATE (C)

(6) CALCITRIOL (C)

(7) CALCIUM CITRATE\COLECALCIFEROL (C)

(8) COLECALCIFEROL (C)

N/A
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(9) FLUDROCORTISONE (C)

(10) LEVOTHYROXINE (C)

(11) DOCUSATE SODIUM (C)

(12) MAGNESIUM CITRATE (C)

(13) AMOXICILLIN\CLAVULANATE POTASSIUM (T)

(14) VANCOMYCIN (T)

(15) CEFEPIME (T)

(16) HYDROCODONE BITARTRATE\PARACETAMOL (T)
2799593
58
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pleural infection
Grade 3
117
(1) PRALSETINIB (S)

(2) LORAZEPAM (C)

(3) LOSARTAN POTASSIUM (C)

(4) PANTOPRAZOLE (C)

(5) VANCOMYCIN (T)

(6) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2799598
70
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
49
(1) PRALSETINIB (S)

(2) AMOXICILLIN\CLAVULANATE POTASSIUM (C)

(3) ENOXAPARIN (C)

(4) METOPROLOL TARTRATE (C)

Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(5) DALTEPARIN (C)

(6) PARACETAMOL (C)

(7) VANCOMYCIN (C)

(8) PANTOPRAZOLE (C)

(9) PIPERACILLIN\TAZOBACTAM (C)

(10) FLUTICASONE PROPIONATE (C)

(11) SENNA SPP. (C)

(12) MACROGOL (C)

(13) OXYCODONE (C)

(14) MAGNESIUM HYDROXIDE (C)

(15) LEVOTHYROXINE (C)

(16) LEVETIRACETAM (C)

(17) ERGOCALCIFEROL (C)

(18) DOCUSATE SODIUM (C)

(19) BISACODYL (C)

(20) BACLOFEN (C)

(21) SODIUM CHLORIDE (C)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(22) CEFEPIME (C)

(23) D-MANNOSE (C)

(24) LEVOFLOXACIN (C)

(25) CEFEPIME HYDROCHLORIDE (T)
2799599
60
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
393
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(4) FUROSEMIDE (C)

(5) METOPROLOL (C)

(6) CANNABIS SATIVA (C)

(7) LOPERAMIDE HYDROCHLORIDE (C)

(8) CALCIUM CARBONATE (C)

(9) PANTOPRAZOLE (C)

(10) LEVOTHYROXINE (C)

(11) FUROSEMIDE (C)

(12) BENZONATATE (C)

(13) ONDANSETRON (C)

(14) PROCHLORPERAZINE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(15) CANNABIDIOL (C)

(16) NITROFURANTOIN (C)

(17) AMOXICILLIN\CLAVULANATE POTASSIUM (T)

(18) LEVOFLOXACIN (T)

(19) CEFEPIME (T)

(20) PIPERACILLIN\TAZOBACTAM (T)

(21) ERTAPENEM (T)

(22) LACTULOSE (T)

(23) PSEUDOEPHEDRINE (T)
2799609
72
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Sepsis

Pneumonia
Grade 4

Grade 3
276

276
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) CETIRIZINE HYDROCHLORIDE (C)

(4) FEXOFENADINE (C)

(5) ACETYLSALICYLIC ACID (C)

(6) XYLITOL (C)

(7) VANCOMYCIN (T)

(8) CEFEPIME (T)

Dose interrupted

Dose interrupted
Pos

Pos
NA

NA
Resolved

Resolved With
Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(9) AMOXICILLIN\CLAVULANIC ACID (T)

(10) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
2799610
67
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Clostridium
difficile colitis

Enterobacter
bacteraemia
Grade 3

Grade 3
29

664
(1) PRALSETINIB (S)
Dose interrupted

Dose interrupted
Pos

Pos
Neg

Neg
Resolved

Resolved
2799615
67
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Sepsis
Grade 3
37
(1) PRALSETINIB (S)

(2) AMITRIPTYLINE (C)

(3) AMLODIPINE (C)

(4) HYDROCORTISONE (C)

(5) LEVOTHYROXINE (C)

(6) FISH OIL (C)

(7) ONDANSETRON (C)

(8) PROMETHAZINE (C)

(9) TRAMADOL (C)

(10) MACROGOL 3350 (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(11) RAMIPRIL (C)

(12) MAGNESIUM HYDROXIDE (C)

(13) SENNA SPP. (C)

(14) AMLODIPINE BESILATE (C)

(15) ENOXAPARIN SODIUM (C)

(16) KETOROLAC TROMETHAMINE (C)

(17) LEVOTHYROXINE SODIUM (C)

(18) LEVOTHYROXINE SODIUM (C)

(19) DOCUSATE SODIUM\SENNA ALEXANDRINA (C)

(20) TRAMADOL HYDROCHLORIDE (C)

(21) VANCOMYCIN HYDROCHLORIDE (C)

(22) ALBUMIN HUMAN (C)

(23) POTASSIUM CHLORIDE (C)

(24) FUROSEMIDE (C)

(25) IOHEXOL (C)

(26) ERTAPENEM SODIUM (C)

(27) METHYLPREDNISOLONE SODIUM SUCCINATE (C)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2799616
71
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumocystis
jirovecii
pneumonia
Grade 3
607
(1) PRALSETINIB (S)

(2) DOCUSATE SODIUM (C)

(3) PARACETAMOL (C)

(4) ONDANSETRON (C)

(5) PROCHLORPERAZINE (C)

(6) GLUCOSAMINE (C)

(7) COLECALCIFEROL (C)

(8) FOLIC ACID (C)

(9) FERROUS SULFATE (C)

(10) DIPHENHYDRAMINE (C)

(11) PREDNISONE (C)

(12) CYANOCOBALAMIN (C)

(13) KETOCONAZOLE (C)

(14) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2799628
58
Female
UNITED STATES
OF AMERICA
Clinical Study
Pneumonia
Grade 3
305
(1) PRALSETINIB (S)

(2) AZELASTINE (C)

(3) CALCIUM CARBONATE (C)

(4) CETIRIZINE (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

(5) FORMOTEROL FUMARATE\MOMETASONE FUROATE
(C)

(6) ESCITALOPRAM (C)

(7) LORAZEPAM (C)

(8) QUINAPRIL (C)

(9) RIVAROXABAN (C)

(10) MEROPENEM (T)
2800335
68
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Sepsis

Pneumonia
Grade 3

Grade 3
44

44
(1) PRALSETINIB (S)

(2) FLUTICASONE\SALMETEROL (C)

(3) COLECALCIFEROL (C)

(4) FAMOTIDINE (C)

(5) LEVOTHYROXINE (C)

(6) MORPHINE (C)

(7) NAPROXEN (C)

(8) OXYCODONE (C)

(9) PROCHLORPERAZINE (C)

(10) DOCUSATE SODIUM\SENNOSIDE A+B (C)

(11) SALBUTAMOL (C)
Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(12) CANNABIDIOL (C)

(13) LORATADINE (C)

(14) IPRATROPIUM\SALBUTAMOL (C)

(15) BENZOCAINE (C)

(16) APIXABAN (C)

(17) GUAIFENESIN (C)

(18) METHYLPREDNISOLONE (C)

(19) DOXYCYCLINE (C)

(20) ROFLUMILAST (C)

(21) CICLESONIDE (C)

(22) PREDNISONE (C)

(23) TRIAMCINOLONE (C)

(24) VANCOMYCIN (C)

(25) AZITHROMYCIN (C)

(26) CEFTRIAXONE (C)

(27) SODIUM CHLORIDE (C)

(28) ENOXAPARIN (C)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(29) GUAIFENESIN (C)

(30) BENZONATATE (C)

(31) FUROSEMIDE (C)

(32) DOCUSATE SODIUM (C)

(33) TIOTROPIUM (C)

(34) LEVOFLOXACIN (C)

(35) METRONIDAZOLE (C)

(36) MACROGOL 3350 (C)

(37) POTASSIUM CHLORIDE (C)

(38) IOPAMIDOL (C)

(39) ACETYLSALICYLIC ACID (C)

(40) AMOXICILLIN\CLAVULANATE POTASSIUM (T)

(41) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(42) VANCOMYCIN (T)

(43) PARACETAMOL (T)

(44) ONDANSETRON (T)

(45) IBUPROFEN (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(46) DICLOFENAC (T)
2800336
47
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
staphylococcal
Grade 3
101
(1) PRALSETINIB (S)

(2) OMEPRAZOLE (C)

(3) ATORVASTATIN CALCIUM (C)

(4) WARFARIN (C)

(5) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(6) COLECALCIFEROL (C)

(7) CALCIUM\MAGNESIUM\ZINC (C)

(8) BISOPROLOL FUMARATE (C)

(9) MIRTAZAPINE (C)

(10) ZOLEDRONIC ACID MONOHYDRATE (C)

(11) LISINOPRIL (C)

(12) SALBUTAMOL (C)

(13) FUROSEMIDE (C)

(14) MACROGOL 3350 (C)

(15) LEVOTHYROXINE (C)

(16) POTASSIUM CHLORIDE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(17) MAGNESIUM OXIDE (C)

(18) VANCOMYCIN (T)

(19) CEFTAZIDIME (T)

(20) CEFEPIME (T)
2800338
61
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Sinusitis bacterial

Sepsis
Grade 3

Grade 4
68

68
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) CLOBETASOL (C)

(4) HYDROCORTISONE (C)

(5) LEVETIRACETAM (C)

(6) LEVOTHYROXINE (C)

(7) LIDOCAINE\PRILOCAINE (C)

(8) ZOLPIDEM (C)

(9) OXYCODONE (C)

(10) MACROGOL 3350 (C)

(11) DIPHENHYDRAMINE HYDROCHLORIDE (C)

(12) SODIUM CHLORIDE (C)

(13) TAMSULOSIN (C)

Dose interrupted

Dose interrupted
Positive

Positive
Negative

Negative
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(14) CEFEPIME (T)

(15) AMPICILLIN (T)

(16) VANCOMYCIN (T)

(17) ACICLOVIR (T)

(18) CEFTRIAXONE (T)
2800345
66
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
legionella
Grade 3
448
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) ENOXAPARIN (C)

(4) LEVOTHYROXINE (C)

(5) SENNA SPP. (C)

(6) SODIUM CHLORIDE (C)

(7) ERGOCALCIFEROL (C)

(8) LEVOTHYROXINE SODIUM (C)

(9) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(10) LEVOFLOXACIN (T)

(11) MINOCYCLINE (T)

(12) METRONIDAZOLE (T)

(13) POTASSIUM CHLORIDE (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2800533
58
Male
SINGAPORE
Clinical Study
Non-healthcare
professional
Pneumonia
Grade 3
300
(1) PRALSETINIB (S)

(2) ACETYLSALICYLIC ACID (C)

(3) ATORVASTATIN (C)

(4) BISOPROLOL (C)

(5) LEVETIRACETAM (C)

(6) NIFEDIPINE (C)

(7) FAMOTIDINE (C)
N/A
N/A
N/A
Not Recovered/Not
Resolved/Ongoing
2800564
42
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia

Clostridium
difficile colitis
Grade 3

Grade 3
958

173
(1) PRALSETINIB (S)

(2) AMITRIPTYLINE (C)

(3) ASCORBIC ACID (C)

(4) BACLOFEN (C)

(5) BUPIVACAINE (C)

(6) CALCIUM CARBONATE (C)

(7) COLECALCIFEROL (C)

(8) DIMENHYDRINATE (C)

(9) DIPHENHYDRAMINE HYDROCHLORIDE (C)

(10) FOLIC ACID (C)

(11) EMPAGLIFLOZIN (C)
Dose not changed

Dose interrupted
N/A

Positive
N/A

Negative
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(12) LAMOTRIGINE (C)

(13) LEVOTHYROXINE (C)

(14) PREGABALIN (C)

(15) MAGNESIUM OXIDE (C)

(16) MORPHINE (C)

(17) ONDANSETRON (C)

(18) OXYCODONE (C)

(19) PIOGLITAZONE HYDROCHLORIDE (C)

(20) THIAMINE (C)

(21) ZINC (C)

(22) COLECALCIFEROL (C)

(23) ATROPINE SULFATE\DIPHENOXYLATE
HYDROCHLORIDE (C)

(24) LOPERAMIDE HYDROCHLORIDE (C)

(25) MORPHINE SULFATE (C)
2800565
64
Female
UNITED STATES
OF AMERICA
Pneumonia
Grade 3
56
(1) PRALSETINIB (S)

(2) BENZONATATE (C)

(3) CEFTRIAXONE SODIUM (C)
Dose interrupted
Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Non-healthcare
professional

(4) OTHER COUGH SUPPRESSANTS AND
EXPECTORANTS (C)

(5) LEVOFLOXACIN (C)

(6) BUTALBITAL\CAFFEINE\PARACETAMOL (C)
2800607
60
Female
KOREA,
REPUBLIC OF
Clinical Study
Non-healthcare
professional
Bacteraemia
Grade 3
68
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) URSODEOXYCHOLIC ACID (C)

(4) AMLODIPINE BESILATE\OLMESARTAN MEDOXOMIL
(C)

(5) CIPROFLOXACIN (T)

(6) CEFTRIAXONE (T)

(7) CEFPODOXIME (T)

(8) PARACETAMOL (T)

(9) ARGININE HYDROCHLORIDE\IBUPROFEN (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae
2800658
70
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Appendicitis
perforated
Grade 3
221
(1) PRALSETINIB (S)

(2) AMLODIPINE BESILATE (C)

(3) ACETYLSALICYLIC ACID (C)

(4) ATORVASTATIN CALCIUM (C)

(5) LEVOTHYROXINE SODIUM (C)
Dose interrupted
Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(6) UBIDECARENONE (C)

(7) FISH OIL (C)

(8) GLUCOSAMINE SULFATE (C)

(9) ENOXAPARIN (C)

(10) MACROGOL 3350 (C)

(11) POTASSIUM CHLORIDE (C)

(12) VITAMIN B COMPLEX (C)

(13) ONDANSETRON (C)

(14) OXYCODONE (C)

(15) METRONIDAZOLE (T)

(16) CEFTRIAXONE (T)
2800660
73
Male
NETHERLANDS
Non-Interventional
Study/Program
Non-healthcare
professional
Pneumonia
Grade 3
4
(1) PRALSETINIB (S)

(2) ACETYLCYSTEINE (C)

(3) APIXABAN (C)

(4) BARNIDIPINE (C)

(5) CICLESONIDE (C)

(6) DIGOXIN (C)

Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(7) EPLERENONE (C)

(8) FORMOTEROL (C)

(9) FOSINOPRIL (C)

(10) FUROSEMIDE (C)

(11) METOPROLOL (C)

(12) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(13) TIOTROPIUM (C)

(14) VENLAFAXINE (C)
2800693
56
Male
KOREA,
REPUBLIC OF
Clinical Study
Non-healthcare
professional
Pneumonia
haemophilus
Grade 3
569
(1) PRALSETINIB (S)

(2) PROPACETAMOL HYDROCHLORIDE (T)

(3) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(4) LEVOFLOXACIN (T)

(5) LENOGRASTIM (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae
2800694
56
Female
SPAIN
Clinical Study
Non-healthcare
professional
Large intestine
infection
Grade 3
238
(1) PRALSETINIB (S)

(2) OMEPRAZOLE (C)

(3) EDOXABAN TOSILATE (C)

(4) PREGABALIN (C)

(5) LORAZEPAM (C)

Dose interrupted
Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(6) MEROPENEM (T)

(7) ERTAPENEM (T)
2800696
65
Male
SPAIN
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
271
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) BISOPROLOL (C)

(4) ACETYLSALICYLIC ACID (C)

(5) TAMSULOSIN (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2800703
51
Female
ITALY
Non-Interventional
Study/Program
Non-healthcare
professional
Clostridium
difficile colitis
Grade 3
21
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) CALCITRIOL (C)

(4) LEVETIRACETAM (C)

(5) FENTANYL (C)

(6) METRONIDAZOLE (C)
Drug withdrawn
Negative
N/A
Not Recovered/Not
Resolved/Ongoing
2800717
79
Female
KOREA,
REPUBLIC OF
Clinical Study
Non-healthcare
professional
Empyema
Grade 3
23
(1) PRALSETINIB (S)

(2) CODEINE (C)

(3) AMBROXOL (C)

(4) AMLODIPINE (C)

(5) SODIUM CHLORIDE (C)

(6) TEPRENONE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(7) URSODEOXYCHOLIC ACID (C)

(8) DIOSMECTITE (C)

(9) ALLIUM SATIVUM OIL\DIMETHYL 4,4'-
BIPHENYLDICARBOXYLATE (C)

(10) ALANINE\ARGININE\CALCIUM CHLORIDE\FISH
OIL\GLUCOSE MONOHYDRATE\GLYCINE\GLYCINE MAX
SEED OIL\HISTIDINE\ISOLEUCINE\LEUCINE\LYSINE
ACETATE\MAGNESIUM SULFATE\MEDIUM-CHAIN
TRIGLYCERIDES\METHIONINE\OLEA EUROPAEA
OIL\PHENYLALANINE\POTASSIUM
CHLORIDE\PROLINE\SERINE\SODIUM ACETATE\SODIUM
GLYCEROPHOSPHATE\TAURINE\THREONINE\TRYPTOP
HAN\TYROSINE\VALINE\ZINC SULFATE (C)

(11) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (C)

(12) VALACICLOVIR (C)

(13) MUPIROCIN (C)

(14) ACICLOVIR (C)

(15) POTASSIUM CHLORIDE (C)

(16) AMBROXOL HYDROCHLORIDE (C)

(17) MORPHINE SULFATE (C)

(18) GLUCOSE (C)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(19) DICLOFENAC (T)

(20) CEFTRIAXONE (T)

(21) PETHIDINE (T)

(22) AMBROXOL ACEFYLLINATE (T)

(23) ZALTOPROFEN (T)

(24) TRAMADOL (T)

(25) METRONIDAZOLE (T)
2800731
69
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Pneumonia
legionella
Grade 3
625
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) LEVOTHYROXINE SODIUM (C)

(4) FAMOTIDINE (C)

(5) FUROSEMIDE (C)

(6) AMLODIPINE BESILATE (C)

(7) ALPRAZOLAM (C)

(8) METOPROLOL SUCCINATE (C)

(9) OSELTAMIVIR PHOSPHATE (T)

(10) CEFALEXIN (T)

(11) AZITHROMYCIN (T)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(12) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
2800736
34
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Pneumonia
Grade 3
763
(1) PRALSETINIB (S)

(2) LISINOPRIL (C)

(3) APIXABAN (C)

(4) DEXTROMETHORPHAN
HYDROBROMIDE\PARACETAMOL\PSEUDOEPHEDRINE
HYDROCHLORIDE (C)

(5) PSEUDOEPHEDRINE HYDROCHLORIDE (C)

(6) MAGNESIUM OXIDE (C)

(7) LEVOTHYROXINE SODIUM (C)

(8) FERROUS SULFATE (C)

(9) POTASSIUM CHLORIDE (C)

(10) ETHINYLESTRADIOL\NORETHISTERONE ACETATE
(C)

(11) LORAZEPAM (C)

(12) ATROPINE (C)

(13) CALCIUM CARBONATE (C)

(14) ERTAPENEM SODIUM (T)

(15) VANCOMYCIN (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2800740
62
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Influenza

Bronchitis
bacterial
Grade 3

Grade 3
517

517
(1) PRALSETINIB (S)

(2) HYDROCHLOROTHIAZIDE\TRIAMTERENE (C)
Dose interrupted

Dose interrupted
Positive

Positive
Negative

Negative
Recovered/Resolve
d

Recovered/Resolve
d
2800761
71
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Herpes zoster
Grade 3
582
(1) PRALSETINIB (S)

(2) GABAPENTIN (C)

(3) LEVOTHYROXINE (C)

(4) TAMSULOSIN (C)

(5) COLECALCIFEROL (C)

(6) LISINOPRIL (C)

(7) PENTOXIFYLLINE (C)

(8) COLLAGENASE (C)

(9) TRAMADOL (C)

(10) DOCUSATE SODIUM (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(11) MACROGOL (C)

(12) ONDANSETRON (C)

(13) DIPHENHYDRAMINE HYDROCHLORIDE (C)

(14) HEPARIN (C)

(15) ACICLOVIR (C)
2800843
61
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Cellulitis
Grade 3
420
(1) PRALSETINIB (S)

(2) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(3) TAMSULOSIN HYDROCHLORIDE (C)

(4) DIPHENHYDRAMINE HYDROCHLORIDE (C)

(5) VITAMIN B COMPLEX (C)

(6) BETAMETHASONE DIPROPIONATE\CLOTRIMAZOLE
(C)

(7) METFORMIN (C)
NR
Unknown
N/A
Recovered/Resolve
d
2800865
33
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Sepsis

Urinary tract
infection

Pyelonephritis
Grade 3

Grade 3

Grade 3
444

444

444
(1) PRALSETINIB (S)

(2) MACROGOL 3350 (C)

(3) LINACLOTIDE (C)

(4) PARACETAMOL (C)

(5) CALCITRIOL (C)

(6) CALCIUM CITRATE\COLECALCIFEROL (C)
Dose interrupted

Dose interrupted

Dose interrupted
Positive

Positive

Positive
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(7) COLECALCIFEROL (C)

(8) FLUDROCORTISONE (C)

(9) LEVOTHYROXINE (C)

(10) PREDNISONE (C)

(11) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(12) HYDROCORTISONE (C)

(13) PARACETAMOL (C)

(14) AMLODIPINE (C)

(15) DOCUSATE SODIUM\SENNOSIDE A+B (C)

(16) HEPARIN (C)

(17) SODIUM CHLORIDE (C)

(18) SACCHAROMYCES BOULARDII (C)

(19) OXYBUTYNIN HYDROCHLORIDE (C)

(20) SENNOSIDE A+B (C)

(21) SULFAMETHOXAZOLE\TRIMETHOPRIM (C)

(22) DIPHENHYDRAMINE\LIDOCAINE (C)

(23) SODIUM CHLORIDE (T)

N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(24) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(25) OXYBUTYNIN HYDROCHLORIDE (T)

(26) NOREPINEPHRINE (T)

(27) METHYLPREDNISOLONE SODIUM SUCCINATE (T)
2800872
67
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Clostridium
difficile colitis

Pneumonia
aspiration
Grade 3

Grade 3
726

730
(1) PRALSETINIB (S)

(2) ASCORBIC ACID (C)

(3) CALCIUM\COLECALCIFEROL (C)

(4) CEFDINIR (C)

(5) CELECOXIB (C)

(6) COLECALCIFEROL (C)

(7) CYANOCOBALAMIN (C)

(8) DICLOFENAC (C)

(9) DIPHENHYDRAMINE (C)

(10) DOCUSATE SODIUM (C)

(11) FUROSEMIDE (C)

(12) GABAPENTIN (C)

(13) PROBIOTICS NOS (C)

Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(14) LEVOTHYROXINE (C)

(15) DIPHENHYDRAMINE\LIDOCAINE (C)

(16) MELATONIN (C)

(17) OMEPRAZOLE (C)

(18) OMEPRAZOLE (C)

(19) CETIRIZINE HYDROCHLORIDE (C)

(20) ONDANSETRON (C)

(21) CIPROFLOXACIN (C)

(22) VANCOMYCIN (T)

(23) METRONIDAZOLE (T)

(24) CEFEPIME (T)
2800875
32
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
486
(1) PRALSETINIB (S)

(2) LINACLOTIDE (C)

(3) METHYLPREDNISOLONE SODIUM SUCCINATE (C)

(4) FLUDROCORTISONE (C)

(5) LEVOTHYROXINE (C)

(6) PREDNISONE (C)

(7) PARACETAMOL (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(8) OXYBUTYNIN (C)

(9) ENOXAPARIN (C)

(10) DOCUSATE SODIUM (C)

(11) FLUCONAZOLE (C)

(12) SODIUM CHLORIDE (C)

(13) AMOXICILLIN (C)

(14) ERTAPENEM (T)

(15) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)
2800887
32
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
534
(1) PRALSETINIB (S)

(2) SENNOSIDE A+B (C)

(3) PARACETAMOL (C)

(4) CALCIUM ASCORBATE (C)

(5) CALCITRIOL (C)

(6) CALCIUM CITRATE\COLECALCIFEROL (C)

(7) COLECALCIFEROL (C)

(8) FLUDROCORTISONE (C)

(9) PREDNISONE (C)

Dose interrupted
Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(10) DIPHENHYDRAMINE\LIDOCAINE (C)

(11) LEVOTHYROXINE (C)

(12) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(13) AMLODIPINE (C)

(14) DOCUSATE SODIUM\SENNOSIDE A+B (C)

(15) MACROGOL 3350 (C)

(16) LINACLOTIDE (C)

(17) OXYBUTYNIN HYDROCHLORIDE (C)

(18) SACCHAROMYCES BOULARDII (C)

(19) ONDANSETRON (C)
2800893
68
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
1095
(1) PRALSETINIB (S)

(2) APIXABAN (C)

(3) DOCUSATE (C)

(4) KETOCONAZOLE (C)

(5) LEVOTHYROXINE (C)

(6) OXYCODONE (C)

(7) PREGABALIN (C)

(8) SENNOSIDE A+B (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(9) ERGOCALCIFEROL (C)
2800896
25
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Proteus infection
Grade 3
912
(1) PRALSETINIB (S)

(2) HYDROCHLOROTHIAZIDE (C)

(3) ONDANSETRON (C)

(4) ZINC SULFATE (C)

(5) CARVEDILOL (C)

(6) HYDRALAZINE HYDROCHLORIDE (C)

(7) AMLODIPINE BESILATE (C)

(8) CALCIUM CARBONATE (C)

(9) ESOMEPRAZOLE (C)

(10) TRAMADOL (C)
Dose interrupted
Positive
Negative
Recovered/Resolve
d
2800897
58
Male
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Healthcare
professional
Sinusitis
aspergillus
Grade 3
918
(1) PRALSETINIB (S)

(2) TETRACYCLINE HYDROCHLORIDE (C)

(3) FEXOFENADINE HYDROCHLORIDE (C)

(4) HYDROTALCITE (C)

(5) GENTAMICIN SULFATE (C)

(6) BRIMONIDINE TARTRATE\TIMOLOL MALEATE (C)

(7) NEOSTIGMINE METILSULFATE (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(8) ACETYLCYSTEINE (C)

(9) BROTIZOLAM (C)

(10) TRAVOPROST (C)

(11) PARACETAMOL (C)

(12) AMOXICILLIN\CLAVULANATE POTASSIUM (C)

(13) NAPROXEN (C)

(14) AMPHOTERICIN B (T)

(15) ASCORBIC ACID (T)

(16) ISAVUCONAZOLE (T)
2800899
59
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Arthritis bacterial
Grade 3
41
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) LOSARTAN (C)

(4) RIVAROXABAN (C)

(5) TRAMADOL (C)

(6) ATORVASTATIN (C)

(7) VENLAFAXINE (C)

(8) DENOSUMAB (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2801025
25
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Sepsis

Urinary tract
infection
Grade 4

Grade 3
675

675
(1) PRALSETINIB (S)

(2) BISACODYL (C)

(3) HYDROCHLOROTHIAZIDE (C)

(4) ONDANSETRON (C)

(5) CARVEDILOL (C)

(6) HYDRALAZINE HYDROCHLORIDE (C)

(7) AMLODIPINE BESILATE (C)

(8) CALCIUM CARBONATE (C)

(9) ZINC SULFATE (C)

(10) ESOMEPRAZOLE (C)

(11) FUROSEMIDE (C)

(12) PARACETAMOL (C)

(13) PARACETAMOL (C)

(14) CALCITRIOL (C)

(15) OXYCODONE HYDROCHLORIDE\PARACETAMOL (C)

(16) PREDNISONE (C)

(17) TRAMADOL (C)
Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2801047
73
Female
FRANCE
Non-Interventional
Study/Program
Non-healthcare
professional
Pyelonephritis
Grade 3
38
(1) PRALSETINIB (S)

(2) CELIPROLOL (C)

(3) INDAPAMIDE (C)

(4) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(5) CEFOTAXIME (T)

(6) OFLOXACIN (T)

(7) RACECADOTRIL (T)

(8) LOPERAMIDE (T)
N/A
N/A
N/A
Recovered/Resolve
d
2801052
44
Female
UNITED
KINGDOM
Clinical Study
Non-healthcare
professional
Lower respiratory
tract infection
Grade 3
335
(1) PRALSETINIB (S)

(2) BETAMETHASONE (C)

(3) LEVETIRACETAM (C)

(4) VALPROATE SODIUM (C)

(5) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d
2801053
79
Female
UNITED
KINGDOM
Non-Interventional
Study/Program
Non-healthcare
professional
Urinary tract
infection
Grade 3
161
(1) PRALSETINIB (S)

(2) SIMVASTATIN (C)

(3) METFORMIN (C)

(4) OMEPRAZOLE (C)

(5) DOXAZOSIN MESILATE (C)

N/A
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(6) CETIRIZINE (C)

(7) LETROZOLE (C)

(8) CANDESARTAN (C)

(9) RANITIDINE (C)

(10) AMOXICILLIN (T)

(11) GENTAMICIN (T)
2802005
79
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
796
(1) PRALSETINIB (S)

(2) LORAZEPAM (C)

(3) LEVOTHYROXINE SODIUM (C)

(4) AMLODIPINE BESILATE (C)

(5) APIXABAN (C)

(6) LOSARTAN POTASSIUM (C)

(7) SERTRALINE (C)

(8) CARVEDILOL (C)

(9) OMEPRAZOLE (C)

(10) CYCLOBENZAPRINE (C)

(11) CALCIUM CARBONATE\COLECALCIFEROL (C)

(12) COLECALCIFEROL (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(13) PROPAFENONE (C)

(14) CEFUROXIME (T)

(15) CEFEPIME (T)

(16) CEFTRIAXONE (T)

(17) METRONIDAZOLE (T)
2802013
80
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Diverticulitis
Grade 3
1095
(1) PRALSETINIB (S)

(2) LORAZEPAM (C)

(3) LEVOTHYROXINE SODIUM (C)

(4) AMLODIPINE BESILATE (C)

(5) APIXABAN (C)

(6) LOSARTAN POTASSIUM (C)

(7) SERTRALINE (C)

(8) CARVEDILOL (C)

(9) OMEPRAZOLE (C)

(10) CYCLOBENZAPRINE (C)

(11) CALCIUM CARBONATE\COLECALCIFEROL (C)

(12) COLECALCIFEROL (C)

Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(13) PROPAFENONE (C)

(14) METRONIDAZOLE (T)

(15) CEFTRIAXONE (T)
2802023
74
Male
SINGAPORE
Clinical Study
Non-healthcare
professional
Pneumonia
Grade 3
44
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) METHYLPREDNISOLONE (T)

(4) PARACETAMOL (T)

(5) MEROPENEM (T)

(6) LEVOFLOXACIN (T)

(7) SALBUTAMOL (T)

(8) IPRATROPIUM BROMIDE\SALBUTAMOL SULFATE (T)

(9) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2802048
57
Female
SINGAPORE
Clinical Study
Non-healthcare
professional
Sepsis
Grade 3
33
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(4) VANCOMYCIN (T)

(5) MEROPENEM (T)

(6) ACETYLSALICYLIC ACID (T)
Drug withdrawn
Negative
N/A
Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(7) DEXAMETHASONE PHOSPHATE (T)
2802118
68
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Clostridium
difficile colitis
Grade 3
1095
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) CEFALEXIN (C)

(4) LEVOFLOXACIN (C)

(5) ERYTHROMYCIN (C)

(6) CLARITHROMYCIN (C)

(7) METRONIDAZOLE (C)

(8) FEXOFENADINE HYDROCHLORIDE (C)

(9) FERROUS SULFATE (C)

(10) FLUDROCORTISONE (C)

(11) HYDROCORTISONE (C)

(12) LEVOTHYROXINE (C)

(13) MAGNESIUM OXIDE (C)

(14) MONTELUKAST SODIUM (C)

(15) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(16) TOPIRAMATE (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(17) RIVAROXABAN (C)

(18) METOCLOPRAMIDE HYDROCHLORIDE (C)

(19) MORPHINE SULFATE (C)

(20) ONDANSETRON (C)

(21) VANCOMYCIN (T)
2802120
57
Male
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Non-healthcare
professional
Septic arthritis
staphylococcal


Grade 3
194
(1) PRALSETINIB (S)

(2) VALSARTAN (C)

(3) CLOBETASOL PROPIONATE (C)

(4) LEVOTHYROXINE SODIUM (C)

(5) TAMSULOSIN HYDROCHLORIDE (C)

(6) CEFUROXIME (C)

(7) OXYBUTYNIN HYDROCHLORIDE (C)

(8) AMBROXOL HYDROCHLORIDE (C)

(9) NAPROXEN (C)

(10) TRANEXAMIC ACID (C)

(11) ALGELDRATE (C)

(12) ALBUMIN HUMAN (C)

(13) BETHANECHOL CHLORIDE (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(14) HYDROTALCITE (C)

(15) MAGNESIUM OXIDE (C)

(16) MORPHINE (C)

(17) POTASSIUM GLUCONATE (C)

(18) SENNOSIDE A+B CALCIUM (C)

(19) PARACETAMOL\TRAMADOL HYDROCHLORIDE (C)

(20) DEXTROMETHORPHAN HYDROBROMIDE (C)

(21) PARACETAMOL (T)

(22) DICLOFENAC (T)

(23) MEPHENOXALONE (T)

(24) CHLORZOXAZONE (T)

(25) BACLOFEN (T)

(26) DICLOXACILLIN SODIUM MONOHYDRATE (T)
2802122
83
Male
SINGAPORE
Clinical Study
Non-healthcare
professional
Cystitis
Grade 3
298
(1) PRALSETINIB (S)

(2) CEFUROXIME (C)

(3) AMLODIPINE (C)

(4) ACETYLSALICYLIC ACID (C)

Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(5) CEFEPIME (T)

(6) MEROPENEM (T)
2802315
67
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Clostridium
difficile colitis

Pneumonia
Grade 3

Grade 3
473

473
(1) PRALSETINIB (S)

(2) MONTELUKAST SODIUM (C)

(3) LEVOTHYROXINE SODIUM (C)

(4) HYDROCORTISONE (C)

(5) FLUDROCORTISONE ACETATE\FRAMYCETIN
SULFATE\GRAMICIDIN (C)

(6) TOPIRAMATE (C)

(7) RIVAROXABAN (C)

(8) SALBUTAMOL (C)

(9) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(10) GABAPENTIN (C)

(11) CYANOCOBALAMIN (C)

(12) MACROGOL 3350 (C)

(13) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(14) MELATONIN (C)

(15) MACROGOL\PROPYLENE
GLYCOL\SIMETICONE\SORBIC ACID\SORBITOL\WHITE
Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
SOFT PARAFFIN (C)

(16) POTASSIUM CHLORIDE (C)

(17) LORAZEPAM (C)

(18) CODEINE (C)

(19) FLUTICASONE PROPIONATE (C)

(20) IPRATROPIUM BROMIDE (C)

(21) FORMOTEROL FUMARATE\MOMETASONE FUROATE
(C)

(22) PARACETAMOL (T)

(23) DOXYCYCLINE (T)

(24) VANCOMYCIN (T)

(25) FIDAXOMICIN (T)

(26) METOPROLOL (T)
2802351
52
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Pneumonia

Streptococcal
bacteraemia
Grade 3

Grade 4
95

95
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) ESOMEPRAZOLE (C)

(4) GABAPENTIN (C)

(5) LEVOTHYROXINE (C)

Dose not changed

Dose not changed
N/A

N/A
N/A

N/A
Recovered/Resolve

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(6) PIOGLITAZONE (C)

(7) POTASSIUM CHLORIDE (C)

(8) PRAMIPEXOLE (C)

(9) FORMOTEROL FUMARATE\MOMETASONE FUROATE
(C)

(10) TIOTROPIUM BROMIDE MONOHYDRATE (C)

(11) CANNABIS SATIVA (C)

(12) PROCHLORPERAZINE (C)

(13) CALCITRIOL (C)

(14) SERTRALINE (C)

(15) SALBUTAMOL (C)
d

Recovered/Resolve
d
2802359
71
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Diverticulitis
Grade 3
15
(1) PRALSETINIB (S)

(2) NAPROXEN SODIUM (C)

(3) RIVAROXABAN (C)

(4) DOXYCYCLINE (C)

(5) CHLORHEXIDINE GLUCONATE (C)

(6) LEVOTHYROXINE SODIUM (C)

(7) FLECAINIDE ACETATE (C)

Dose interrupted
Positive
Unknown
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(8) LANSOPRAZOLE (C)

(9) LORATADINE (C)

(10) PARACETAMOL (C)

(11) ACETYLSALICYLIC ACID\CAFFEINE (C)

(12) ESTRADIOL (C)

(13) CHLORHEXIDINE (C)

(14) METRONIDAZOLE (C)

(15) PROMETHAZINE (C)

(16) AZTREONAM (T)
2802367
59
Female
FRANCE
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
29
(1) PRALSETINIB (S)

(2) MEROPENEM TRIHYDRATE (T)

(3) CIPROFLOXACIN (T)

(4) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d
2811141
65
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
279
(1) PRALSETINIB (S)

(2) DIPHENHYDRAMINE
HYDROCHLORIDE\PARACETAMOL (C)

(3) DOCUSATE SODIUM (C)

(4) LEVOTHYROXINE (C)

(5) VANCOMYCIN (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(6) CEFEPIME (T)
2812765
61
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
767
(1) PRALSETINIB (S)

(2) CEFTRIAXONE (T)

(3) AZITHROMYCIN (T)

(4) DEXAMETHASONE (T)

(5) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)
Dose interrupted
Positive
Negative
Recovered/Resolve
d
2830078
63
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia

Pneumonia
Grade 3

Grade 3
270

978
(1) PRALSETINIB (S)

(2) LEVOFLOXACIN HYDROCHLORIDE (T)

(3) PIPERACILLIN SODIUM\SULBACTAM SODIUM (T)

(4) MONTELUKAST SODIUM (T)

(5) DICLOFENAC SODIUM (T)

(6) POTASSIUM CHLORIDE (T)

(7) ASCORBIC ACID (T)

(8) PYRIDOXINE HYDROCHLORIDE (T)

(9) COIX LACRYMA-JOBI VAR. MA-YUEN SEED (T)

(10) AMBROXOL HYDROCHLORIDE (T)

(11) ISOLEUCINE\LEUCINE\VALINE (T)
Drug withdrawn

Dose not changed
Positive

N/A
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d
2841030
56
Pyelonephritis
Grade 3
522
(1) PRALSETINIB (S)

Dose not changed
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Female
SPAIN
Clinical Study
Healthcare
professional
(2) TRIMETHOPRIM (C)

(3) SULFAMETHOXAZOLE (C)

(4) MEROPENEM (T)

(5) ERTAPENEM (T)
N/A
Recovered/Resolve
d
2849630
72
Male
SPAIN
Clinical Study
Healthcare
professional
Cellulitis
Grade 3
807
(1) PRALSETINIB (S)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae
2871834
58
Female
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
555
(1) PRALSETINIB (S)

(2) PARACETAMOL\TRAMADOL HYDROCHLORIDE (C)

(3) AMLODIPINE BESILATE (C)

(4) METOPROLOL SUCCINATE (C)

(5) ESOMEPRAZOLE (C)

(6) LEVOTHYROXINE SODIUM (C)

(7) AMOXICILLIN\CLAVULANATE POTASSIUM (C)

(8) DOXYCYCLINE (C)

(9) NEOMYCIN (C)

(10) MAGNESIUM OXIDE (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(11) ENTECAVIR (C)

(12) FUROSEMIDE (C)

(13) SERTACONAZOLE NITRATE (C)

(14) HYDROCORTISONE ACETATE (C)

(15) DEXTROMETHORPHAN HYDROBROMIDE (C)

(16) DIMETICONE (C)

(17) FLUCONAZOLE (C)

(18) FAMOTIDINE (C)

(19) DIMETICONE (C)

(20) DIOSMECTITE (C)

(21) MOSAPRIDE CITRATE (C)

(22) HYDROTALCITE (C)

(23) PREDNISOLONE (C)

(24) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(25) PARACETAMOL (T)
2880117
56
Male
UNITED
KINGDOM
COVID-19
Grade 3
1095
(1) PRALSETINIB (S)

(2) LANSOPRAZOLE (C)

(3) LEVOTHYROXINE (C)
Dose interrupted
Positive
Negative
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional

(4) BISOPROLOL (C)

(5) CALCIUM CARBONATE (C)

(6) ALFACALCIDOL (C)

(7) SALBUTAMOL (C)

(8) SILDENAFIL (C)

(9) TERBINAFINE (C)
3021613
63
Female
INDIA
Non-Interventional
Study/Program
Healthcare
professional
Urinary tract
infection

Sepsis

Urosepsis
Grade 4

Grade 4

Grade 3
NR

NR

NR
(1) PRALSETINIB (S)

(2) BENDAMUSTINE (C)

(3) RITUXIMAB (C)
NR

NR

NR
Unknown

Unknown

Unknown
N/A

N/A

N/A
Not Recovered/Not
Resolved/Ongoing

Not Recovered/Not
Resolved/Ongoing


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Recovered/Resolve
d
2708978
55
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
969
(1) PRALSETINIB (S)

(2) CALCIUM CITRATE (S)

(3) LOPERAMIDE (C)

(4) METOPROLOL SUCCINATE (C)

(5) LEVOTHYROXINE SODIUM (C)

(6) CALCITRIOL (C)

(7) PARACETAMOL (C)

(8) BENZONATATE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2728572
55
Female
FRANCE
Non-Interventional
Study/Program
Non-healthcare
professional
COVID-19
Grade 3
100
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) PROPRANOLOL (C)

(4) AMLODIPINE (C)

(5) VALSARTAN (C)

(6) HYDROCORTISONE (C)
NR
Unknown
N/A
Recovering/Resolvin
g
2746101
71
Male
CHINA
Pneumonia
Grade 3
12
(1) PRALSETINIB (S)

(2) ATORVASTATIN (C)

Dose not changed
N/A
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Non-healthcare
professional
(3) METOPROLOL (C)

(4) ACETYLSALICYLIC ACID (C)

(5) SALBUTAMOL (C)

(6) SALMETEROL (C)

(7) DOXAZOSIN (C)
Recovered/Resolve
d
2759488
58
Male
SPAIN
Clinical Study
Non-healthcare
professional
Diverticulitis
Grade 3
374
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) CALCITRIOL (C)

(4) HYDROCORTISONE (C)

(5) OMEPRAZOLE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2788519
35
Male
GERMANY
Clinical Study
Non-healthcare
professional
Appendicitis
Grade 3
462
(1) PRALSETINIB (S)

(2) PIPERACILLIN (C)

(3) ENOXAPARIN SODIUM (C)

(4) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(5) RED BLOOD CELLS (C)

(6) LEVOTHYROXINE (C)

(7) COLECALCIFEROL (C)

(8) ACETYLSALICYLIC ACID (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2788564
65
Male
SPAIN
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
100
(1) PRALSETINIB (S)

(2) TAMSULOSIN (C)

(3) PYRIDOSTIGMINE BROMIDE (C)

(4) LEVOTHYROXINE (C)

(5) ESOMEPRAZOLE (C)

(6) BISOPROLOL (C)

(7) ACETYLSALICYLIC ACID (C)

(8) TICAGRELOR (C)

(9) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(10) FOSFOMYCIN (T)

(11) COLECALCIFEROL (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2788591
50
Female
CHINA
Clinical Study
Non-healthcare
professional
Pneumonia
Grade 3
155
(1) PRALSETINIB (S)

(2) RED BLOOD CELLS (C)

(3) IRON (C)

(4) ERYTHROPOIETIN HUMAN (C)

(5) CABOZANTINIB (C)

(6) MOXIFLOXACIN (T)

(7) CEFOPERAZONE\SULBACTAM SODIUM (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(8) IRON POLYSACCHARIDE COMPLEX (T)

(9) RECOMBINANT HUMAN THROMBOPOIETIN (T)

(10) ALBUMIN HUMAN (T)

(11) FUROSEMIDE (T)
2788594
58
Male
SPAIN
Clinical Study
Non-healthcare
professional
COVID-19
pneumonia
Grade 3
282
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) HYDROCORTISONE (C)

(4) BISOPROLOL (C)

(5) OMEPRAZOLE (C)

(6) AZITHROMYCIN (T)

(7) TOCILIZUMAB (T)

(8) OSELTAMIVIR (T)

(9) HYDROXYCHLOROQUINE (T)

(10) CEFTRIAXONE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2788680
67
Male
CHINA
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
212
(1) PRALSETINIB (S)

(2) TAMSULOSIN HYDROCHLORIDE (T)

(3) FINASTERIDE (T)

(4) CEFOPERAZONE SODIUM (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(5) SULBACTAM SODIUM (T)

(6) LEVOFLOXACIN (T)

(7) SODIUM CHLORIDE (T)

(8) POTASSIUM CHLORIDE (T)

(9) CEFTEZOLE SODIUM (T)
2791305
74
Male
NETHERLANDS
Clinical Study
Non-healthcare
professional
Urinary tract
infection
Grade 3
14
(1) PRALSETINIB (S)

(2) TRAMADOL (C)

(3) HYDROCHLOROTHIAZIDE (C)

(4) TIOTROPIUM BROMIDE MONOHYDRATE (C)

(5) SIMVASTATIN (C)

(6) FLUTICASONE PROPIONATE\SALMETEROL
XINAFOATE (C)

(7) PANTOPRAZOLE (C)

(8) CLOPIDOGREL (C)

(9) RISEDRONIC ACID (C)

(10) TOBRAMYCIN (T)

(11) CLINDAMYCIN (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2887244
64
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection

Sepsis
Grade 3

Grade 3
1095

1095
(1) PRALSETINIB (S)

(2) ALPRAZOLAM (C)

(3) AMLODIPINE BESILATE (C)

(4) ACETYLSALICYLIC ACID (C)

(5) CLONIDINE HYDROCHLORIDE (C)

(6) DENOSUMAB (C)

(7) LEVOTHYROXINE (C)

(8) LISINOPRIL (C)

(9) MUPIROCIN (C)

(10) PREGABALIN (C)

(11) APIXABAN (C)
Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d
2893222
82
Female
FRANCE
Non-Interventional
Study/Program
Non-healthcare
professional
Spinal cord
infection
Grade 3
57
(1) PRALSETINIB (S)

(2) PERINDOPRIL (C)

(3) LEVOTHYROXINE SODIUM (C)
Dose interrupted
Positive
N/A
Recovering/Resolvin
g
2905621
74
Male
UNITED STATES
OF AMERICA
Pneumonia
Grade 3
966
(1) PRALSETINIB (S)

(2) REMDESIVIR (C)

(3) APIXABAN (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional
2911849
37
Male
CHINA
Clinical Study
Healthcare
professional
Pneumocystis
jirovecii
pneumonia
Grade 3
349
(1) PRALSETINIB (S)

(2) GANCICLOVIR (C)

(3) IMMUNOGLOBULIN HUMAN NORMAL (C)

(4) ALBUMIN HUMAN (C)

(5) CALCIUM (C)

(6) POTASSIUM CITRATE (C)

(7) LORATADINE (C)

(8) CETIRIZINE (C)

(9) RABEPRAZOLE (C)

(10) THIAMAZOLE (C)

(11) PROPRANOLOL (C)

(12) DIAMMONIUM GLYCYRRHIZINATE (C)

(13) URSODEOXYCHOLIC ACID (C)

(14) LOPERAMIDE (C)

(15) LEUCOGEN (C)

(16) MOXIFLOXACIN HYDROCHLORIDE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(17) CEFTRIAXONE SODIUM (T)

(18) DEXAMETHASONE SODIUM PHOSPHATE (T)

(19) VORICONAZOLE (T)

(20) CASPOFUNGIN ACETATE (T)

(21) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(22) CEFOPERAZONE SODIUM (T)

(23) SULBACTAM SODIUM (T)
2933058
63
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
COVID-19
Grade 3
681
(1) PRALSETINIB (S)

(2) DOXYCYCLINE (C)

(3) PARACETAMOL (C)

(4) RIVAROXABAN (C)

(5) DEXTROMETHORPHAN HYDROBROMIDE (T)

(6) GUAIFENESIN (T)

(7) DEXAMETHASONE (T)

(8) RIVAROXABAN (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2941299
66
Female
UNITED STATES
OF AMERICA
Pneumonia
Grade 3
722
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) LAMOTRIGINE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional

(4) ATROPINE SULFATE\DIPHENOXYLATE
HYDROCHLORIDE (C)

(5) CALCITRIOL (C)

(6) PARACETAMOL (T)

(7) LAMOTRIGINE (T)

(8) ATROPINE SULFATE\DIPHENOXYLATE
HYDROCHLORIDE (T)

(9) CALCITRIOL (T)

(10) LEVOFLOXACIN (T)
2950270
55
Female
UNITED
KINGDOM
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
95
(1) PRALSETINIB (S)

(2) AMOXICILLIN (C)

(3) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing
2951586
68
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Acute sinusitis
Grade 3
1253
(1) PRALSETINIB (S)

(2) PARACETAMOL (T)

(3) CEFEPIME (T)

(4) VANCOMYCIN (T)

(5) CEFPODOXIME (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2960715
59
Male
SPAIN
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
876
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) CALCITRIOL (C)

(4) HYDROCORTISONE (C)

(5) FLUDROCORTISONE (C)

(6) OMEPRAZOLE (C)

(7) LORAZEPAM (C)

(8) BISOPROLOL (C)

(9) ALLOPURINOL (C)

(10) COLECALCIFEROL (C)

(11) TELMISARTAN (C)

(12) PRAVASTATIN (C)

(13) CEFIXIME (T)
Dose interrupted
Positive
Negative
Recovered/Resolve
d
2972605
71
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
556
(1) PRALSETINIB (S)

(2) ALPRAZOLAM (C)

(3) ATENOLOL (C)

(4) BRIMONIDINE TARTRATE\TIMOLOL MALEATE (C)

(5) CALCIUM\COLECALCIFEROL (C)
Dose interrupted
Positive
N/A
Recovering/Resolvin
g

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(6) CYCLOBENZAPRINE HYDROCHLORIDE (C)

(7) BIMATOPROST (C)

(8) OMEPRAZOLE (C)

(9) OXYCODONE HYDROCHLORIDE (C)

(10) PREDNISOLONE ACETATE (C)

(11) DOCUSATE SODIUM\SENNOSIDE A+B (C)

(12) SUCRALFATE (C)

(13) VALACICLOVIR HYDROCHLORIDE (C)

(14) ACETYLSALICYLIC ACID (C)
2979246
36
Male
GERMANY
Clinical Study
Healthcare
professional
Respiratory tract
infection
Grade 3
1095
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) CALCITRIOL (C)

(4) RAMIPRIL (C)

(5) CALCIUM BROMIDE (C)

(6) SODIUM PERCHLORATE (C)

(7) ZOLEDRONIC ACID MONOHYDRATE (C)

(8) ESOMEPRAZOLE (C)

Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(9) AMOXICILLIN (T)

(10) CLAVULANATE POTASSIUM (T)
2979290
60
Male
NETHERLANDS
Clinical Study
Healthcare
professional
Hepatitis B
reactivation

Escherichia
sepsis
Grade 3

Grade 3
629

631
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) SIMVASTATIN (C)

(4) METOPROLOL (C)

(5) OMEPRAZOLE (C)

(6) CLINDAMYCIN (C)

(7) SILDENAFIL CITRATE (C)

(8) SODIUM CHLORIDE (C)

(9) TENOFOVIR DISOPROXIL FUMARATE (T)

(10) CEFTRIAXONE (T)

(11) CIPROFLOXACIN (T)
Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d
2988503
60
Female
SPAIN
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
673
(1) PRALSETINIB (S)

(2) PREGABALIN (C)

(3) ZOLPIDEM (C)

(4) ESCITALOPRAM (C)

(5) BEMIPARIN (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(6) REMDESIVIR (T)

(7) TOCILIZUMAB (T)
3022018
65
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
87
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) HEPARIN SODIUM (C)

(4) BENZYDAMINE HYDROCHLORIDE (C)

(5) INOSINE PRANOBEX (C)

(6) ACETYLCYSTEINE (C)

(7) BEPOTASTINE NICOTINATE (C)

(8) PELUBIPROFEN (C)

(9) REBAMIPIDE (C)

(10) REBAMIPIDE (C)

(11) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(12) SODIUM CHLORIDE (T)

(13) PIPERACILLIN\TAZOBACTAM (T)

(14) PROPACETAMOL HYDROCHLORIDE (T)

(15) ERDOSTEINE (T)

(16) LEVOFLOXACIN (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(17) AMMONIUM CHLORIDE\CHLORPHENAMINE
MALEATE\DIHYDROCODEINE
BITARTRATE\METHYLEPHEDRINE HYDROCHLORIDE-DL
(T)
3025451
27
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection

Klebsiella urinary
tract infection

COVID-19
Grade 3

Grade 3

Grade 3
342

342

342
(1) PRALSETINIB (S)

(2) CEFEPIME (T)
Dose interrupted

Dose interrupted

Dose interrupted
Positive

Positive

Positive
Unknown

Unknown

Unknown
Recovered/Resolve
d

Recovered/Resolve
d

Recovered/Resolve
d
3041085
78
Female
FRANCE
Clinical Study
Staphylococcal
sepsis
Grade 3
289
(1) PRALSETINIB (S)

(2) TINZAPARIN SODIUM (C)

(3) MACROGOL 3350\POTASSIUM CHLORIDE\SODIUM
BICARBONATE\SODIUM CHLORIDE (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

(4) PARACETAMOL (C)

(5) TRAMADOL HYDROCHLORIDE (C)

(6) MIANSERIN (C)

(7) SUFENTANIL (C)

(8) CEFAZOLIN SODIUM (T)
3048492
61
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
1095
(1) PRALSETINIB (S)

(2) ZOLPIDEM TARTRATE (C)

(3) ATORVASTATIN CALCIUM (C)

(4) CITALOPRAM HYDROBROMIDE (C)

(5) GUAIFENESIN (C)

(6) PROCHLORPERAZINE (C)

(7) DEXBROMPHENIRAMINE
MALEATE\DEXTROMETHORPHAN
HYDROBROMIDE\PSEUDOEPHEDRINE
HYDROCHLORIDE (C)

(8) MACROGOL 3350 (C)

(9) PROGESTERONE (C)

(10) SENNA SPP. (C)

(11) ALPRAZOLAM (C)
Dose interrupted
Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(12) LEVOFLOXACIN (T)
3053461
45
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
82
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) SALBUTAMOL (C)

(4) LEVOTHYROXINE (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d
3072556
55
Female
UNITED
KINGDOM
Clinical Study
Healthcare
professional
Pneumocystis
jirovecii
pneumonia
Grade 3
54
(1) PRALSETINIB (S)

(2) MORPHINE SULFATE PENTAHYDRATE (C)

(3) FLUTICASONE FUROATE (C)

(4) LEVOTHYROXINE SODIUM (C)

(5) NYSTATIN (C)

(6) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(7) VANCOMYCIN (T)

(8) MEROPENEM (T)

(9) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(10) DEXAMETHASONE (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d
3073175
49
Female
SPAIN
Clinical Study
Pneumonia
Grade 3
87
(1) PRALSETINIB (S)

(2) LEVOFLOXACIN (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional
3073178
69
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
12
(1) PRALSETINIB (S)

(2) CHLORPHENAMINE MALEATE (C)

(3) AMLODIPINE (C)

(4) GLUCONATE SODIUM\MAGNESIUM
CHLORIDE\POTASSIUM CHLORIDE\SODIUM
ACETATE\SODIUM CHLORIDE (C)

(5) PANTOPRAZOLE (C)

(6) ENOXAPARIN (C)

(7) TRAMADOL (C)

(8) METOCLOPRAMIDE (C)

(9) ALMAGATE (C)

(10) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(11) PARACETAMOL (T)

(12) LEVOFLOXACIN (T)

(13) DEXAMETHASONE (T)

(14) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(15) REMDESIVIR (T)

Dose interrupted
Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(16) LACTULOSE (T)

(17) AMBROXOL (T)
3077668
54
Male
GERMANY
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
794
(1) PRALSETINIB (S)

(2) CANDESARTAN (C)

(3) INFLUENZA VACCINE INACT SPLIT 4V (C)

(4) DICLOFENAC (C)

(5) CURCUMIN (C)

(6) PANTOPRAZOLE (C)

(7) DENOSUMAB (C)

(8) CALCIUM (C)

(9) METAMIZOLE (C)

(10) FLUPREDNIDENE ACETATE\MICONAZOLE NITRATE
(C)

(11) CLOTRIMAZOLE (C)

(12) ENOXAPARIN (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d With Sequelae
3107480
53
Female
KOREA,
REPUBLIC OF
Clinical Study
Pneumocystis
jirovecii
pneumonia

Pneumonia
cytomegaloviral
Grade 3
161

161
(1) PRALSETINIB (S)

(2) CEFRADINE (C)

(3) FAMOTIDINE (C)

(4) POLYCARBOPHIL CALCIUM (C)
Dose interrupted

Dose interrupted
Positive

Negative
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

Grade 3

(5) AMINO ACIDS
NOS\CALCIUM\GLUCOSE\MAGNESIUM\POTASSIUM\SODI
UM (C)

(6) METHYLPREDNISOLONE SODIUM SUCCINATE (C)

(7) FUROSEMIDE (C)

(8) TEICOPLANIN (C)

(9) GANCICLOVIR (C)

(10) BROMHEXINE HYDROCHLORIDE (C)

(11) MAGNESIUM OXIDE (C)

(12) URSODEOXYCHOLIC ACID (C)

(13) ADENINE HYDROCHLORIDE\CARNITINE
OROTATE\CYANOCOBALAMIN\LIVER\PYRIDOXINE
HYDROCHLORIDE\RIBOFLAVIN (C)

(14) LACTULOSE (C)

(15) SODIUM BICARBONATE (C)

(16) BENZYDAMINE HYDROCHLORIDE (C)

(17) CEFPODOXIME PROXETIL (C)

(18) NOREPINEPHRINE (C)

(19) INSULIN HUMAN (C)

N/A
Recovered/Resolve
d With Sequelae

Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(20) PARACETAMOL (C)

(21) LEVOFLOXACIN (T)

(22) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(23) PREDNISOLONE (T)

(24) CEFPODOXIME PROXETIL (T)

(25) CEFDINIR (T)

(26) METHYLPREDNISOLONE SODIUM SUCCINATE (T)

(27) LEVOFLOXACIN (T)

(28) LEVODROPROPIZINE (T)

(29) ERDOSTEINE (T)

(30) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(31) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(32) CODEINE (T)

(33) FLUCONAZOLE (T)

(34) ACETYLCYSTEINE (T)

(35) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(36) CORYDALIS YANHUSUO TUBER\IPOMOEA NIL SEED

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(T)

(37) IPRATROPIUM BROMIDE (T)
3112750
71
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
NR
(1) PRALSETINIB (S)

(2) AMLODIPINE\BENAZEPRIL (C)

(3) LEVOTHYROXINE SODIUM (C)

(4) IMIQUIMOD (C)

(5) LOTEPREDNOL ETABONATE (C)

(6) TADALAFIL (C)

(7) IPRATROPIUM BROMIDE\SALBUTAMOL SULFATE (T)

(8) AMPICILLIN SODIUM\SULBACTAM SODIUM (T)

(9) AMOXICILLIN\CLAVULANATE POTASSIUM (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d
3136179
66
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pseudomembran
ous colitis

Urinary tract
infection bacterial
Grade 3

Grade 3
752

752
(1) PRALSETINIB (S)

(2) CLINDAMYCIN (C)

(3) VANCOMYCIN (C)

(4) LEVOFLOXACIN (C)

(5) METRONIDAZOLE (C)

(6) FIDAXOMICIN (C)

(7) BEZLOTOXUMAB (C)

Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(8) CEFEPIME (C)

(9) METRONIDAZOLE (C)
3150236
90
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Colonic abscess

Clostridium
difficile infection
Grade 3

Grade 3
56

196
(1) PRALSETINIB (S)

(2) ATORVASTATIN (C)

(3) BACLOFEN (C)

(4) FISH OIL (C)

(5) DRONABINOL (C)

(6) OXYCODONE\PARACETAMOL (C)

(7) MORPHINE (C)

(8) MELATONIN (C)

(9) LEVOFLOXACIN (C)

(10) SIMETICONE (C)

(11) NYSTATIN (C)

(12) POTASSIUM (C)

(13) TAMSULOSIN (C)

(14) MIRABEGRON (C)

(15) SOLIFENACIN (C)

(16) TAMSULOSIN HYDROCHLORIDE (C)
Dose not changed

Dose interrupted
N/A

Negative
N/A

Unknown
Recovered/Resolve
d

Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(17) RED BLOOD CELLS (C)

(18) MACROGOL 3350 (C)

(19) AMOXICILLIN\CLAVULANIC ACID (C)

(20) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(21) SODIUM CHLORIDE (T)

(22) CIPROFLOXACIN (T)

(23) METRONIDAZOLE (T)

(24) AMOXICILLIN\CLAVULANATE POTASSIUM (T)

(25) ATROPINE SULFATE\DIPHENOXYLATE
HYDROCHLORIDE (T)

(26) AMOXICILLIN (T)

(27) FLUCONAZOLE (T)

(28) CEFEPIME (T)

(29) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(30) METRONIDAZOLE (T)

(31) LOPERAMIDE HYDROCHLORIDE (T)

(32) VANCOMYCIN (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
3161561
80
Male
NETHERLANDS
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
67
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) RIVAROXABAN (C)

(4) OMEPRAZOLE (C)

(5) TRAMADOL (C)

(6) DOXYCYCLINE (T)

(7) CEFTRIAXONE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae
3165353
56
Female
GERMANY
Clinical Study
Healthcare
professional
Osteomyelitis
Grade 3
743
(1) PRALSETINIB (S)

(2) MACROGOL 3350\POTASSIUM CHLORIDE\SODIUM
BICARBONATE\SODIUM CHLORIDE (C)

(3) CLOMIFENE CITRATE (C)

(4) DEXAMETHASONE (C)

(5) INSULIN GLARGINE (C)

(6) INSULIN GLULISINE (C)

(7) METHOCARBAMOL (C)

(8) ZOLEDRONIC ACID MONOHYDRATE (C)

(9) CEFUROXIME (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d
3169545
61
Female
Pneumonia
Grade 3
459
(1) PRALSETINIB (S)

(2) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
Dose not changed
N/A
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
GERMANY
Clinical Study
Healthcare
professional

(3) PREDNISOLONE (T)
Recovered/Resolve
d
3177824
57
Female
CHINA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
866
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) CALCIUM CARBONATE (C)

(4) PANTOPRAZOLE (C)

(5) PIPERACILLIN\TAZOBACTAM (C)

(6) CALCIUM GLUCONATE (C)

(7) ALFACALCIDOL (C)

(8) ACARBOSE (C)

(9) MEGESTROL ACETATE (C)

(10) POTASSIUM CHLORIDE (C)

(11) ASCORBIC ACID (C)

(12) PYRIDOXINE HYDROCHLORIDE (C)

(13) POTASSIUM CHLORIDE (C)

(14) INSULIN NOS (C)

(15) GLUTATHIONE (C)

Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(16) CILASTATIN SODIUM\IMIPENEM (C)

(17) VALACICLOVIR HYDROCHLORIDE (C)

(18) GABAPENTIN (C)

(19) MECOBALAMIN (C)

(20) ACICLOVIR (C)

(21) CLOTRIMAZOLE\UREA (C)

(22) KETOROLAC TROMETHAMINE (C)

(23) ROSUVASTATIN CALCIUM (C)

(24) CALCIUM GLUCONATE (C)

(25) CEFOPERAZONE SODIUM\SULBACTAM SODIUM (T)
3187619
68
Female
PORTUGAL
Clinical Study
Healthcare
professional
Pneumonia
legionella
Grade 3
57
(1) PRALSETINIB (S)

(2) PIPERACILLIN (C)

(3) TAZOBACTAM (C)

(4) MORPHINE (C)

(5) NYSTATIN (C)

(6) METAMIZOLE MAGNESIUM (C)

(7) FLUCONAZOLE (C)

(8) ONDANSETRON (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(9) PARACETAMOL (C)

(10) AMOXICILLIN\CLAVULANIC ACID (C)
3189337
69
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
COVID-19
Grade 3
1460
(1) PRALSETINIB (S)

(2) REMDESIVIR (C)

(3) FOLIC ACID (C)

(4) OXYMETAZOLINE (C)

(5) FUROSEMIDE (C)

(6) HYDROCORTISONE (C)
NR
Unknown
N/A
Recovered/Resolve
d
3193488
71
Female
GERMANY
Clinical Study
Healthcare
professional
Diverticulitis
intestinal
perforated
Grade 3
29
(1) PRALSETINIB (S)

(2) POTASSIUM IODIDE (C)

(3) HYDROCHLOROTHIAZIDE (C)

(4) CITRIC ACID\POTASSIUM BICARBONATE\POTASSIUM
CITRATE (C)

(5) AMPICILLIN (C)

(6) SULBACTAM (C)

(7) METHIONINE (T)
NR
Unknown
N/A
Recovered/Resolve
d
3208425
72
Female
KOREA,
REPUBLIC OF
Pneumonia
Grade 3
62
(1) PRALSETINIB (S)

(2) TELMISARTAN (C)

(3) AMLODIPINE BESILATE (C)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional

(4) ROSUVASTATIN CALCIUM (C)

(5) EZETIMIBE (C)

(6) CALCIUM CARBONATE\COLECALCIFEROL (C)

(7) URSODEOXYCHOLIC ACID (C)

(8) NALOXONE HYDROCHLORIDE\OXYCODONE
HYDROCHLORIDE (C)

(9) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(10) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(11) FLUCONAZOLE (T)

(12) METHYLPREDNISOLONE SODIUM SUCCINATE (T)

(13) SALBUTAMOL SULFATE (T)

(14) ACETYLCYSTEINE (T)

(15) LEVOFLOXACIN (T)

(16) MEROPENEM (T)

(17) GANCICLOVIR (T)

(18) TEICOPLANIN (T)

(19) IPRATROPIUM BROMIDE (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
3214967
65
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Influenza
Grade 3
258
(1) PRALSETINIB (S)

(2) SACCHAROMYCES BOULARDII (C)

(3) ITOPRIDE HYDROCHLORIDE (C)

(4) MAGNESIUM OXIDE (C)

(5) MELATONIN (C)

(6) TRAZODONE (C)

(7) PREGABALIN (C)

(8) LEVOTHYROXINE SODIUM (C)

(9) CARVEDILOL (C)

(10) AMLODIPINE BESILATE (C)

(11) CANDESARTAN CILEXETIL (C)

(12) FOLIC ACID (C)

(13) ALANINE\ARGININE\ASPARTIC
ACID\CYSTEINE\GLUTAMIC
ACID\GLYCINE\HISTIDINE\ISOLEUCINE\LEUCINE\LYSINE
ACETATE\METHIONINE\PHENYLALANINE\PROLINE\SERI
NE\THREONINE\TRYPTOPHAN\TYROSINE\VALINE (C)

(14) GLUCOSE (C)

(15) LACTULOSE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(16) ERTAPENEM SODIUM (T)
3222777
73
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Cellulitis
Grade 3
143
(1) PRALSETINIB (S)

(2) ACECLOFENAC (C)

(3) EUGENOL\GLYCINE\LEVOMENTHOL\SODIUM
BICARBONATE (C)

(4) LOPERAMIDE HYDROCHLORIDE (C)

(5) PARACETAMOL\TRAMADOL HYDROCHLORIDE (C)

(6) CODEINE PHOSPHATE\IBUPROFEN\PARACETAMOL
(C)

(7) AMLODIPINE
BESILATE\CHLORTALIDONE\TELMISARTAN (C)

(8) GLUCONATE SODIUM\MAGNESIUM
CHLORIDE\POTASSIUM CHLORIDE\SODIUM
ACETATE\SODIUM CHLORIDE (C)

(9) GLUCOSE (C)

(10) TRAMADOL HYDROCHLORIDE (C)

(11) SODIUM CHLORIDE (C)

(12) PARACETAMOL (C)

(13) ALBUMIN HUMAN (C)

(14) METOCLOPRAMIDE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(15) ESOMEPRAZOLE (C)

(16) MAGNESIUM SULFATE (C)

(17) CALCIUM GLUCONATE (C)

(18) POTASSIUM PHOSPHATE MONOBASIC (C)

(19) FUROSEMIDE (C)

(20) ACICLOVIR (C)

(21) REMDESIVIR (C)

(22) CHLORHEXIDINE GLUCONATE (C)

(23) FENTANYL (C)

(24) POTASSIUM CHLORIDE\SODIUM CHLORIDE (C)

(25) CHLORPHENAMINE MALEATE\DIHYDROCODEINE
BITARTRATE\GUAIFENESIN\METHYLEPHEDRINE
HYDROCHLORIDE-DL (C)

(26) ERDOSTEINE (C)

(27) NOREPINEPHRINE (T)

(28) CEFAZOLIN (T)

(29) MEROPENEM TRIHYDRATE (T)

(30) TEICOPLANIN (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(31) HYDROCORTISONE SODIUM SUCCINATE (T)

(32) CEFTRIAXONE SODIUM (T)

(33) METRONIDAZOLE (T)

(34) DOXYCYCLINE (T)

(35) MUPIROCIN (T)

(36) ACICLOVIR (T)
3225257
66
Male
BRAZIL
Clinical Study
Healthcare
professional
Urinary tract
infection

Cystitis
Grade 3

Grade 3
210

220
(1) PRALSETINIB (S)

(2) ROSUVASTATIN (C)

(3) COLECALCIFEROL (C)

(4) METAMIZOLE SODIUM (C)

(5) LACTULOSE (C)

(6) LOSARTAN (C)

(7) CALCITRIOL (C)

(8) CALCIUM CARBONATE\COLECALCIFEROL (C)

(9) APIXABAN (C)

(10) METOPROLOL (C)

(11) METFORMIN (C)

Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d With Sequelae

Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(12) LEVOTHYROXINE (C)

(13) PROPAFENONE HYDROCHLORIDE (C)

(14) BUDESONIDE\FORMOTEROL FUMARATE (C)

(15) METAMIZOLE SODIUM (C)

(16) PARACETAMOL (C)

(17) DICLOFENAC (C)

(18) TAMSULOSIN (C)

(19) CIPROFLOXACIN (T)

(20) TAMSULOSIN HYDROCHLORIDE (T)
3235328
68
Female
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
195
(1) PRALSETINIB (S)

(2) AMLODIPINE BESILATE\VALSARTAN (C)

(3) NEBIVOLOL (C)

(4) SENNOSIDE A+B (C)

(5) LEVOTHYROXINE SODIUM (C)

(6) SITAGLIPTIN (C)

(7) ROSUVASTATIN (C)

(8) DIMETICONE (C)

(9) DIPHENHYDRAMINE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(10) BISACODYL (C)

(11) POTASSIUM GLUCONATE (C)

(12) THIAMINE (C)

(13) PARACETAMOL (C)

(14) PIOGLITAZONE (C)

(15) ACETYLCYSTEINE (C)

(16) ALBUMIN HUMAN (C)

(17) AMBROXOL (C)

(18) DIOSMECTITE (C)

(19) FUROSEMIDE (C)

(20) IPRATROPIUM BROMIDE\SALBUTAMOL SULFATE (C)

(21) POTASSIUM CHLORIDE (C)

(22) MORPHINE (C)

(23) PROPACETAMOL (C)

(24) AMPICILLIN\SULBACTAM (C)

(25) DOXYCYCLINE (C)

(26) FLUCONAZOLE (C)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(27) MEROPENEM (C)

(28) PIPERACILLIN\TAZOBACTAM (C)

(29) AMLODIPINE (C)

(30) ZINC OXIDE (C)

(31) CEFACLOR (T)

(32) CEFIXIME (T)

(33) CEFTRIAXONE (T)

(34) PIPERACILLIN\TAZOBACTAM (T)

(35) CIPROFLOXACIN (T)

(36) CEFEPIME (T)
3235960
69
Female
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Healthcare
professional
Pneumonia

Pneumonia
aspiration
Grade 3

Grade 3
209

246
(1) PRALSETINIB (S)

(2) AMLODIPINE BESILATE\VALSARTAN (C)

(3) NEBIVOLOL (C)

(4) SITAGLIPTIN (C)

(5) ROSUVASTATIN (C)

(6) DIMETICONE (C)

(7) CEFACLOR (C)

Dose not changed

Dose interrupted
Positive

Negative
N/A

N/A
Recovered/Resolve
d

Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(8) CEFIXIME (C)

(9) CEFTRIAXONE (C)

(10) PIPERACILLIN (C)

(11) CEFEPIME (C)

(12) BISACODYL (C)

(13) POTASSIUM GLUCONATE (C)

(14) THIAMINE (C)

(15) PARACETAMOL (C)

(16) DIPHENHYDRAMINE (C)

(17) SENNOSIDE A+B (C)

(18) PIOGLITAZONE (C)

(19) DIOSMECTITE (C)

(20) POTASSIUM CHLORIDE (C)

(21) PROPACETAMOL (C)

(22) FUROSEMIDE (C)

(23) AMLODIPINE (C)

(24) ZINC OXIDE (C)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(25) RED BLOOD CELLS (C)

(26) LENVATINIB (C)

(27) CIPROFLOXACIN (T)

(28) AMPICILLIN SODIUM\SULBACTAM SODIUM (T)

(29) SULBACTAM (T)

(30) ACETYLCYSTEINE (T)

(31) ALBUMIN HUMAN (T)

(32) AMBROXOL (T)

(33) IPRATROPIUM (T)

(34) MORPHINE (T)

(35) AMPICILLIN\SULBACTAM (T)

(36) DOXYCYCLINE (T)

(37) FLUCONAZOLE (T)

(38) MEROPENEM (T)

(39) PIPERACILLIN\TAZOBACTAM (T)
3241415
53
Male
FRANCE
Clinical Study
Intervertebral
discitis
Grade 3
109
(1) PRALSETINIB (S)

(2) TESTOSTERONE ENANTHATE (C)

(3) OXYCODONE HYDROCHLORIDE (C)
Dose reduced
Negative
N/A
Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

(4) PREDNISOLONE METASULFOBENZOATE SODIUM (C)

(5) AMITRIPTYLINE HYDROCHLORIDE (C)

(6) POTASSIUM CHLORIDE (C)

(7) CALCIUM CARBONATE (C)

(8) METHADONE (C)

(9) HYDROCORTISONE (C)

(10) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (C)

(11) CIPROFLOXACIN (C)

(12) ENOXAPARIN SODIUM (C)

(13) ONDANSETRON (C)

(14) SULFAMETHOXAZOLE\TRIMETHOPRIM (C)

(15) AMOXICILLIN (C)

(16) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(17) TOBRAMYCIN (T)

(18) CIPROFLOXACIN (T)
3253616
79
Female
SPAIN
Infection
Grade 3
88
(1) PRALSETINIB (S)

(2) MEROPENEM (T)

Dose not changed
N/A
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional
(3) DAPTOMYCIN (T)

(4) DALBAVANCIN (T)

(5) CIPROFLOXACIN (T)

(6) DOXYCYCLINE (T)
Recovering/Resolvin
g
3254775
34
Male
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
52
(1) PRALSETINIB (S)

(2) ARTEMISIA ANNUA HERB\GARDENIA JASMINOIDES
FRUIT\LONICERA JAPONICA FLOWER BUD (C)

(3) CEFOPERAZONE SODIUM\SULBACTAM SODIUM (C)

(4) METOCLOPRAMIDE (C)

(5) AMBROXOL HYDROCHLORIDE (C)

(6) POTASSIUM CHLORIDE (C)

(7) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (C)

(8) DEXAMETHASONE SODIUM PHOSPHATE (C)

(9) ESOMEPRAZOLE MAGNESIUM (C)

(10) LOW MOLECULAR WEIGHT HEPARIN, CALCIUM
SALT (C)

(11) DICLOFENAC SODIUM (C)

(12) KETOROLAC TROMETHAMINE (C)

(13) ZOLEDRONIC ACID (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
3270069
79
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia

Sepsis
Grade 3

Grade 4
909

1125
(1) PRALSETINIB (S)

(2) LEVOFLOXACIN (C)

(3) SULFAMETHOXAZOLE\TRIMETHOPRIM (C)

(4) AMIODARONE (C)
Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovering/Resolvin
g
3283245
68
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
1095
(1) PRALSETINIB (S)

(2) OXYCODONE (C)

(3) GABAPENTIN (C)

(4) TIZANIDINE (C)

(5) VANCOMYCIN (T)

(6) CEFEPIME (T)

(7) CEFDINIR (T)

(8) AMOXICILLIN\CLAVULANATE POTASSIUM (T)

(9) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(10) FAMOTIDINE (T)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(11) METOCLOPRAMIDE (T)

(12) ONDANSETRON (T)
3300007
66
Male
BRAZIL
Clinical Study
Non-healthcare
professional
COVID-19
Grade 3
309
(1) PRALSETINIB (S)

(2) ROSUVASTATIN (C)

(3) COLECALCIFEROL (C)

(4) LOSARTAN (C)

(5) METAMIZOLE SODIUM (C)

(6) LACTULOSE (C)

(7) CALCITRIOL (C)

(8) CALCIUM CARBONATE\COLECALCIFEROL (C)

(9) APIXABAN (C)

(10) BUDESONIDE\FORMOTEROL FUMARATE (C)

(11) METOPROLOL (C)

(12) PARACETAMOL (C)

(13) METFORMIN (C)

(14) DICLOFENAC (C)

(15) PROPAFENONE HYDROCHLORIDE (C)

(16) TRIMETHOPRIM,SULFAMETHOXAZOLE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(17) BUDESONIDE\FORMOTEROL FUMARATE (C)

(18) TAMSULOSIN (C)

(19) LEVOTHYROXINE (C)

(20) REMDESIVIR (T)

(21) CEFTRIAXONE (T)

(22) METHYLPREDNISOLONE (T)

(23) PARACETAMOL (T)

(24) CLARITHROMYCIN (T)
3310666
38
Male
GERMANY
Clinical Study
Healthcare
professional
Atypical
pneumonia

Pneumonia


Grade 3

Grade 3
1510

1526
(1) PRALSETINIB (S)

(2) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (C)

(3) VANDETANIB (C)
Dose interrupted

Dose interrupted
Positive

Positive
Positive

Positive
Recovered/Resolve
d

Recovered/Resolve
d
3315664
56
Female
JAPAN
Sepsis
Grade 3
11
(1) PRALSETINIB (S)

(2) METOCLOPRAMIDE (C)

Dose interrupted
Positive
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional
(3) BACILLUS MESENTERICUS\CLOSTRIDIUM
BUTYRICUM\ENTEROCOCCUS FAECALIS (C)

(4) FENTANYL CITRATE (C)

(5) HYDROMORPHONE HYDROCHLORIDE (C)

(6) LOXOPROFEN SODIUM DIHYDRATE (C)

(7) REBAMIPIDE (C)

(8) FEXOFENADINE HYDROCHLORIDE (C)

(9) PARACETAMOL (C)

(10) MIRTAZAPINE (C)

(11) HYDROCORTISONE (C)

(12) SODIUM GUALENATE HYDRATE (C)

(13) MOSAPRIDE CITRATE (C)

(14) LEMBOREXANT (C)

(15) HEPARINOID (C)

(16) BETAMETHASONE VALERATE (C)

(17) THIAMAZOLE (C)

(18) DICLOFENAC SODIUM (C)

(19) FERRIC SODIUM CITRATE (C)
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(20) OXYCODONE HYDROCHLORIDE TRIHYDRATE (C)

(21) LANSOPRAZOLE (C)

(22) CALCIUM POLYSTYRENE SULFONATE (C)

(23) AMLODIPINE BESILATE (C)

(24) ESOMEPRAZOLE (C)

(25) GUAIAZULENE (C)

(26) BLOOD, WHOLE (T)

(27) CALCIUM CHLORIDE DIHYDRATE\POTASSIUM
CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE (T)

(28) PIPERACILLIN\TAZOBACTAM (T)

(29) PARACETAMOL (T)

(30) OMEPRAZOLE (T)

(31) CLOSTRIDIUM BUTYRICUM (T)

(32) CLAVULANATE POTASSIUM (T)

(33) AMOXICILLIN TRIHYDRATE (T)

(34) RED BLOOD CELLS, LEUCOCYTE DEPLETED (T)
3328401
43
Male
Gastroenteritis
Grade 3
259
(1) PRALSETINIB (S)

(2) BUDESONIDE\FORMOTEROL FUMARATE (C)
Dose not changed
N/A
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
SPAIN
Clinical Study
Healthcare
professional

(3) METOCLOPRAMIDE (C)

(4) DEXKETOPROFEN TROMETAMOL (C)

(5) OXYCODONE (C)

(6) NALOXONE (C)

(7) FENTANYL (C)

(8) SITAGLIPTIN (C)

(9) CIPROFLOXACIN (T)
Recovered/Resolve
d
3355841
61
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
985
(1) PRALSETINIB (S)

(2) METHOXYPHENAMINE (C)

(3) DEXTROMETHORPHAN HYDROBROMIDE (C)

(4) ACETYLCYSTEINE (C)

(5) MONTELUKAST SODIUM (C)

(6) BROMHEXINE HYDROCHLORIDE (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae
3363793
52
Female
UNITED
KINGDOM
Clinical Study
Healthcare
professional
Staphylococcal
bacteraemia
Grade 3
571
(1) PRALSETINIB (S)

(2) ALFACALCIDOL (C)

(3) BISACODYL (C)

(4) LEVOTHYROXINE (C)

(5) PREGABALIN (C)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(6) BECLOMETASONE DIPROPIONATE (C)

(7) SERTRALINE (C)

(8) FOLIC ACID (C)

(9) SALBUTAMOL (C)

(10) LANSOPRAZOLE (C)

(11) BETAMETHASONE VALERATE\FUSIDIC ACID (T)

(12) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)
3363904
63
Female
SWITZERLAND
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
567
(1) PRALSETINIB (S)

(2) METAMIZOLE (C)

(3) LOSARTAN (C)

(4) ROSUVASTATIN (C)

(5) ESCITALOPRAM (C)

(6) METFORMIN (C)

(7) PANTOPRAZOLE (C)

(8) INSULIN NOS (C)

(9) LERCANIDIPINE (C)

(10) PREGABALIN (C)

NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(11) AMITRIPTYLINE (C)

(12) CEFTRIAXONE SODIUM (T)
3364578
65
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Herpes zoster
Grade 3
467
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) FOLIC ACID (C)

(4) TAMSULOSIN HYDROCHLORIDE (C)

(5) BETHANECHOL CHLORIDE (C)

(6) AMLODIPINE BESILATE (C)

(7) CANDESARTAN CILEXETIL (C)

(8) ACICLOVIR (T)

(9) GABAPENTIN (T)

(10) TRAMADOL (T)

(11) PARACETAMOL\TRAMADOL HYDROCHLORIDE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
3374277
73
Female
IRELAND
Clinical Study
Healthcare
professional
Kidney infection
Grade 3
206
(1) PRALSETINIB (S)

(2) CEFTRIAXONE SODIUM (T)

(3) AMIKACIN (T)

(4) AMOXICILLIN (T)
Dose not changed
N/A
N/A
Not Recovered/Not
Resolved/Ongoing
3375129
60
Male
Spontaneous
bacterial
peritonitis
887

887
(1) PRALSETINIB (S)
Dose interrupted

Dose interrupted

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
ITALY
Clinical Study
Non-healthcare
professional

Herpes zoster
Grade 3

Grade 3
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d
3410119
40
Male
AUSTRALIA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
47
(1) PRALSETINIB (S)

(2) TEMAZEPAM (C)

(3) CALCIUM (C)

(4) COLECALCIFEROL (C)

(5) SERTRALINE (C)

(6) TRAMADOL (C)

(7) CODEINE PHOSPHATE\PARACETAMOL (C)

(8) PREGABALIN (C)

(9) IRON (C)

(10) MACROGOL 3350\POTASSIUM CHLORIDE\SODIUM
BICARBONATE\SODIUM CHLORIDE (C)

(11) AMLODIPINE (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(12) PARACETAMOL (C)

(13) OXYCODONE HYDROCHLORIDE (C)

(14) AMOXICILLIN\CLAVULANIC ACID (C)

(15) METOCLOPRAMIDE (C)

(16) CLARITHROMYCIN (C)

(17) AMITRIPTYLINE (C)

(18) CALCITRIOL (C)

(19) METFORMIN (C)

(20) AZITHROMYCIN (T)

(21) CEFAZOLIN (T)

(22) CEFTRIAXONE (T)

(23) ENOXAPARIN (T)

(24) MAGNESIUM ASPARTATE (T)

(25) METHYLPREDNISOLONE (T)

(26) PANTOPRAZOLE (T)

(27) PIPERACILLIN\TAZOBACTAM (T)

(28) FENTANYL (T)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(29) ONDANSETRON (T)

(30) PROPOFOL (T)

(31) SUXAMETHONIUM (T)

(32) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(33) CEFALEXIN (T)

(34) PREDNISOLONE (T)
3473059
67
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Peritonitis
bacterial
Grade 3
1825
(1) PRALSETINIB (S)

(2) CEFEPIME (T)

(3) VANCOMYCIN (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d
3474000
54
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia


Grade 3
71
(1) PRALSETINIB (S)

(2) ERGOCALCIFEROL (C)

(3) TRIAMCINOLONE ACETONIDE (C)

(4) DOCUSATE\SENNA ALEXANDRINA (C)

(5) ENOXAPARIN SODIUM (C)

(6) TRAMADOL (C)

(7) GABAPENTIN (C)

(8) AMPICILLIN SODIUM\SULBACTAM SODIUM (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(9) FAMOTIDINE (C)

(10) MAGNESIUM HYDROXIDE (C)

(11) ONDANSETRON (C)

(12) CELECOXIB (C)

(13) HYDROMORPHONE HYDROCHLORIDE (C)

(14) PARACETAMOL (C)

(15) BISACODYL (C)

(16) KETOROLAC TROMETHAMINE (C)

(17) SACCHAROMYCES BOULARDII (C)
3489162
67
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pneumonia
cytomegaloviral
Grade 3
84
(1) PRALSETINIB (S)

(2) DIHYDROCODEINE BITARTRATE (C)

(3) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (C)

(4) LEVOFLOXACIN (C)

(5) AMBROXOL HYDROCHLORIDE (C)

(6) PARACETAMOL (C)

(7) METHYLPREDNISOLONE (C)

(8) ESOMEPRAZOLE (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(9) CODEINE PHOSPHATE (C)

(10) SULFAMETHOXAZOLE\TRIMETHOPRIM (C)

(11) FENTANYL (C)

(12) POTASSIUM PHOSPHATE MONOBASIC (C)

(13) ZOLPIDEM TARTRATE (C)

(14) QUETIAPINE FUMARATE (C)

(15) CHLORPHENAMINE MALEATE (C)

(16) METOCLOPRAMIDE (C)

(17) MEGESTROL ACETATE (C)

(18) POTASSIUM CHLORIDE (C)

(19) PREDNISOLONE (C)

(20) TRAMADOL HYDROCHLORIDE (C)

(21) PREGABALIN (C)

(22) MELATONIN (C)

(23) CILOSTAZOL (C)
3495221
65
Male
MEXICO
Clinical Study
Pneumonia


Grade 3
367
(1) PRALSETINIB (S)

(2) LERCANIDIPINE (C)

(3) LEVOFLOXACIN (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Non-healthcare
professional
3495267
65
Female
MEXICO
Clinical Study
Healthcare
professional
Urosepsis
Grade 3
34
(1) PRALSETINIB (S)

(2) ESOMEPRAZOLE (C)

(3) PREGABALIN (C)

(4) SIMVASTATIN (C)

(5) TELMISARTAN (C)

(6) DIMETICONE\MAGALDRATE (C)

(7) METFORMIN (C)

(8) FILGRASTIM (T)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing
3499350
64
Male
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Non-healthcare
professional
Cryptococcosis
Grade 3
230
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) FLUVASTATIN (C)

(4) DEXTROMETHORPHAN (C)

(5) AMBROXOL HYDROCHLORIDE (C)

(6) FEXOFENADINE (C)

(7) OLMESARTAN (C)

(8) TETRACYCLINE (C)

(9) GENTAMICIN (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(10) PARACETAMOL (C)

(11) ACETYLCYSTEINE (C)

(12) SULTAMICILLIN (C)

(13) CEFAZOLIN SODIUM (C)

(14) CELECOXIB (C)

(15) AMOXICILLIN\CLAVULANIC ACID (C)

(16) CALCIUM CHLORIDE\POTASSIUM
CHLORIDE\SODIUM LACTATE (C)

(17) GLUCOSE MONOHYDRATE\SODIUM CHLORIDE (C)

(18) ESOMEPRAZOLE (C)

(19) NALBUPHINE HYDROCHLORIDE (C)

(20) MAGNESIUM OXIDE (C)

(21) SENNOSIDE A+B (C)

(22) NEBIVOLOL (C)

(23) ESOMEPRAZOLE MAGNESIUM (C)

(24) NIRMATRELVIR\RITONAVIR (C)

(25) FLUCONAZOLE (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
3500851
57
Male
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
94
(1) PRALSETINIB (S)

(2) METFORMIN HYDROCHLORIDE (C)

(3) AMLODIPINE BESILATE (C)

(4) LINAGLIPTIN (C)

(5) DIMETICONE (C)

(6) MORPHINE (C)

(7) LANSOPRAZOLE (C)

(8) SERTACONAZOLE NITRATE (C)

(9) SENNOSIDE A+B (C)

(10) ACETYLCYSTEINE (C)

(11) MOSAPRIDE CITRATE (C)

(12) VALSARTAN (C)

(13) MAGNESIUM OXIDE (C)

(14) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (C)

(15) NYSTATIN (C)

(16) CLINDAMYCIN (C)

(17) RABEPRAZOLE SODIUM (C)

Dose reduced
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(18) GLYCYRRHIZA GLABRA EXTRACT\PAPAVER
SOMNIFERUM\PIMPINELLA ANISUM OIL (C)

(19) CEFIXIME (C)

(20) NYSTATIN (C)

(21) FEXOFENADINE HYDROCHLORIDE (C)

(22) CLINDAMYCIN (C)

(23) AMOXICILLIN\CLAVULANIC ACID (C)

(24) CEFIXIME (C)
3524202
66
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Appendicitis
Grade 3
738
(1) PRALSETINIB (S)

(2) CARVEDILOL (C)

(3) TAMSULOSIN HYDROCHLORIDE (C)

(4) BETHANECHOL CHLORIDE (C)

(5) SACCHAROMYCES BOULARDII (C)

(6) ITOPRIDE HYDROCHLORIDE (C)

(7) MAGNESIUM OXIDE (C)

(8) MELATONIN (C)

(9) TRAZODONE (C)

(10) PREGABALIN (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(11) LANSOPRAZOLE (C)

(12) LEVOTHYROXINE SODIUM (C)

(13) NIRMATRELVIR\RITONAVIR (C)

(14) CEFTRIAXONE SODIUM (C)

(15) BROMHEXINE HYDROCHLORIDE (C)

(16) COPTIS SPP. RHIZOME\HEDERA HELIX LEAF (C)

(17) AMLODIPINE BESILATE (C)

(18) CANDESARTAN CILEXETIL (C)

(19) FOLIC ACID (C)

(20) PROTAMINE SULFATE (C)

(21) ERTAPENEM SODIUM (C)

(22) ACICLOVIR (C)

(23) GABAPENTIN (C)

(24) PARACETAMOL\TRAMADOL HYDROCHLORIDE (C)

(25) LACTULOSE (C)
3548756
69
Male
NETHERLANDS
Clinical Study
Pneumonia
Grade 3
228
(1) PRALSETINIB (S)

(2) CARBOPLATIN (S)

(3) PEMETREXED (S)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Non-healthcare
professional

(4) PARACETAMOL (C)

(5) AMLODIPINE (C)

(6) ENALAPRIL (C)

(7) MACROGOL (C)

(8) AMOXICILLIN TRIHYDRATE\CLAVULANATE
POTASSIUM (T)

(9) VANCOMYCIN (T)

(10) CEFTAZIDIME (T)
2717111
71
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Sepsis

COVID-19
pneumonia

Pneumonia
staphylococcal
Grade 5

Grade 3

Grade 3
50

20

47
(1) PRALSETINIB (S)

(2) BACLOFEN (C)

(3) LEVETIRACETAM (C)

(4) LEVOTHYROXINE (C)

(5) METOPROLOL TARTRATE (C)

(6) ONDANSETRON (C)

(7) RIVAROXABAN (C)

(8) AMLODIPINE (C)

(9) DOCUSATE (C)

(10) FLUTICASONE (C)
N/A

Dose interrupted

Dose interrupted
N/A

Negative

Negative
N/A

N/A

N/A
Fatal

Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(11) GABAPENTIN (C)

(12) NITROFURANTOIN (C)

(13) OXYBUTYNIN (C)

(14) TIZANIDINE (C)

(15) IPRATROPIUM BROMIDE\SALBUTAMOL SULFATE (C)

(16) DEXAMETHASONE (T)

(17) REMDESIVIR (T)

(18) RIVAROXABAN (T)

(19) PARACETAMOL (T)

(20) FERROUS SULFATE (T)

(21) IBUPROFEN (T)

(22) LEVETIRACETAM (T)

(23) MACROGOL 3350 (T)

(24) OXYBUTYNIN HYDROCHLORIDE (T)

(25) SENNA SPP. (T)

(26) SODIUM CHLORIDE (T)

(27) BENZONATATE (T)

Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(28) VANCOMYCIN (T)
3355432
77
Female
FRANCE
Clinical Study
Healthcare
professional
Pyelonephritis

Pneumonia
Grade 3

Grade 5
16

29
(1) PRALSETINIB (S)

(2) ATORVASTATIN (C)

(3) PANTOPRAZOLE (C)

(4) PERINDOPRIL (C)

(5) LEVOTHYROXINE SODIUM (C)

(6) APIXABAN (C)

(7) LAMOTRIGINE (C)

(8) PROPRANOLOL (C)

(9) ZOPICLONE (C)

(10) CEFTRIAXONE (T)

(11) METRONIDAZOLE (T)

(12) CEFOTAXIME (T)

(13) FUROSEMIDE (T)

(14) SPIRAMYCIN (T)

(15) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
Dose interrupted

NR
Positive

Unknown
Unknown

Unknown
Recovered/Resolve
d

Fatal

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(16) CEFEPIME (T)
2711982
71
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
819
(1) PRALSETINIB (S)

(2) AMLODIPINE BESILATE (C)

(3) ACETYLSALICYLIC ACID (C)

(4) ATORVASTATIN CALCIUM (C)

(5) UBIQUINOL (C)

(6) FISH OIL (C)

(7) LEVOTHYROXINE SODIUM (C)

(8) VITAMIN B COMPLEX (C)

(9) DEXAMETHASONE (T)

(10) REMDESIVIR (T)

(11) AZITHROMYCIN (T)
Dose interrupted
Positive
Negative
Recovered/Resolve
d
2713020
35
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
285
(1) PRALSETINIB (S)

(2) CALCIUM CARBONATE (C)

(3) COLECALCIFEROL (C)

(4) LEUCOGEN (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d With Sequelae
2713199
55
Female
Device related
infection
Grade 3
21
(1) PRALSETINIB (S)
Dose interrupted
Positive
Unknown

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
GERMANY
Clinical Study
Healthcare
professional
Recovered/Resolve
d With Sequelae
2713664
66
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
63
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) ASCORBIC ACID (T)

(4) PYRIDOXINE HYDROCHLORIDE (T)

(5) POTASSIUM CHLORIDE (T)

(6) CEFACLOR (T)
NR
Unknown
N/A
Recovered/Resolve
d
2714763
27
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection

Sepsis
Grade 3

Grade 3
941

1072
(1) PRALSETINIB (S)

(2) HYDROCHLOROTHIAZIDE (C)

(3) ONDANSETRON (C)

(4) ZINC SULFATE (C)

(5) CARVEDILOL (C)

(6) HYDRALAZINE HYDROCHLORIDE (C)

(7) AMLODIPINE BESILATE (C)

(8) CALCIUM CARBONATE (C)

(9) ESOMEPRAZOLE MAGNESIUM (C)

(10) TRAMADOL (C)
Dose interrupted

Dose interrupted
Positive

Positive
Negative

Negative
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(11) PARACETAMOL (C)

(12) VACCINIUM SPP. (C)

(13) DOCUSATE SODIUM (C)

(14) ERGOCALCIFEROL (C)

(15) ESCITALOPRAM OXALATE (C)

(16) HYDROCHLOROTHIAZIDE (C)

(17) LACTOBACILLUS ACIDOPHILUS (C)

(18) LACTULOSE (C)

(19) LORAZEPAM (C)

(20) NITROFURANTOIN (C)

(21) ONDANSETRON (C)

(22) CALCIUM CARBONATE (C)

(23) ESOMEPRAZOLE (C)

(24) ESOMEPRAZOLE (C)

(25) LEVOFLOXACIN (T)

(26) HYDROCHLOROTHIAZIDE (T)

(27) METOPROLOL TARTRATE (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2715770
55
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
94
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) PIPERACILLIN\TAZOBACTAM (T)
N/A
N/A
N/A
Recovered/Resolve
d
2716421
33
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
625
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) CALCIUM ASCORBATE (C)

(4) CALCITRIOL (C)

(5) CALCIUM CITRATE\COLECALCIFEROL (C)

(6) COLECALCIFEROL (C)

(7) FLUDROCORTISONE (C)

(8) PREDNISONE (C)

(9) LEVOTHYROXINE (C)

(10) DIPHENHYDRAMINE\LIDOCAINE (C)

(11) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(12) AMLODIPINE (C)

(13) DOCUSATE SODIUM\SENNOSIDE A+B (C)

(14) MACROGOL 3350 (C)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(15) LINACLOTIDE (C)

(16) MACROGOL (C)
2716423
58
Male
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
327
(1) PRALSETINIB (S)

(2) ENTECAVIR (C)

(3) NIFEDIPINE (C)

(4) IRON POLYSACCHARIDE COMPLEX (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2717065
31
Male
CHINA
Clinical Study
Healthcare
professional
Appendicitis
Grade 3
176
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) SODIUM CHLORIDE (T)

(4) CEFUROXIME SODIUM (T)

(5) PETHIDINE HYDROCHLORIDE (T)

(6) ORNIDAZOLE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2717177
73
Female
FRANCE
Non-Interventional
Study/Program
Healthcare
professional
Clostridium
difficile infection

Klebsiella
infection
Grade 3

Grade 3
118

38
(1) PRALSETINIB (S)

(2) SPIRONOLACTONE (C)

(3) CELIPROLOL (C)

(4) INDAPAMIDE (C)

(5) LANSOPRAZOLE (C)

(6) VANCOMYCIN (T)

Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(7) PIPERACILLIN (T)

(8) OXYGEN (T)

(9) CEFOTAXIME (T)

(10) OFLOXACIN (T)

(11) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
Recovered/Resolve
d
2717198
55
Female
FRANCE
Non-Interventional
Study/Program
Healthcare
professional
Pneumonia
aspiration
Grade 3
130
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) PROPRANOLOL (C)

(4) NICARDIPINE (C)

(5) IRBESARTAN (C)

(6) HYDROCORTISONE (C)

(7) ATEZOLIZUMAB (C)

(8) RUCAPARIB (C)

(9) ALFACALCIDOL (C)

(10) FOLIC ACID (C)

(11) PARACETAMOL (C)

(12) PAROXETINE HYDROCHLORIDE (C)

(13) MIRTAZAPINE (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(14) GABAPENTIN (C)

(15) AMITRIPTYLINE HYDROCHLORIDE (C)

(16) OXYCODONE HYDROCHLORIDE (C)

(17) OXYCODONE HYDROCHLORIDE (C)

(18) DESLORATADINE (C)

(19) LEVOCETIRIZINE DIHYDROCHLORIDE (C)
2718490
60
Male
FRANCE
Clinical Study
Healthcare
professional
COVID-19
Grade 3
469
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) RED BLOOD CELLS (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2718745
35
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
367
(1) PRALSETINIB (S)

(2) LOXOPROFEN (T)

(3) PIDOTIMOD (T)

(4) CEFUROXIME SODIUM (T)

(5) FLUCONAZOLE\SODIUM CHLORIDE (T)

(6) DESARMILLARIA TABESCENS (T)

(7) CALCIUM GLUCONATE\GLUCOSE\MAGNESIUM
CHLORIDE\POTASSIUM CHLORIDE\SODIUM
ACETATE\SODIUM CHLORIDE\SODIUM CITRATE (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(8) POTASSIUM CHLORIDE (T)

(9) SODIUM CHLORIDE (T)

(10) REBAMIPIDE (T)

(11) SODIUM BICARBONATE (T)
2718767
55
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Respiratory tract
infection

Oropharyngeal
candidiasis
Grade 3

Grade 3
552

552
(1) PRALSETINIB (S)

(2) SALBUTAMOL (C)

(3) AMOXICILLIN (C)

(4) AZITHROMYCIN (C)

(5) AZITHROMYCIN (C)

(6) COLECALCIFEROL (C)

(7) FINASTERIDE (C)

(8) CODEINE PHOSPHATE\GUAIFENESIN (C)

(9) LEVOTHYROXINE (C)

(10) LOPERAMIDE HYDROCHLORIDE (C)

(11) GUAIFENESIN (C)

(12) OMEPRAZOLE (C)

(13) ONDANSETRON (C)

Dose interrupted

Dose interrupted
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(14) PREDNISONE (C)

(15) SILDENAFIL (C)

(16) RACEPINEFRINE (T)

(17) FLUCONAZOLE (T)

(18) NYSTATIN (T)

(19) DEXAMETHASONE (T)

(20) CEFTRIAXONE SODIUM (T)
2719938
72
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Lymph node
tuberculosis
Grade 3
214
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) CEFOTAXIME (T)

(4) PROPACETAMOL (T)

(5) TIROPRAMIDE (T)

(6)
BORNEOL\CAMPHENE\CINEOLE\MENTHOL\MENTHONE\
PINENE (T)

(7) URSODEOXYCHOLIC ACID (T)

(8) CIMETROPIUM (T)

(9) METOCLOPRAMIDE (T)

(10) SODIUM CHLORIDE (T)
Dose interrupted


Positive
Positive
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(11) POTASSIUM PHOSPHATE (T)

(12) POTASSIUM CHLORIDE (T)

(13) CHLORPHENAMINE (T)

(14) PARACETAMOL (T)

(15) LEVOFLOXACIN (T)

(16) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(17) MEROPENEM (T)

(18) VANCOMYCIN (T)

(19) PETHIDINE (T)

(20) ISONIAZID (T)

(21) PIPERACILLIN\TAZOBACTAM (T)

(22) RIFAMPICIN (T)

(23) ETHAMBUTOL (T)

(24) PYRIDOXINE (T)

(25) PYRAZINAMIDE (T)

(26) TRAMADOL (T)

(27) MOXIFLOXACIN (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(28) CYCLOSERINE (T)
2723220
54
Female
GERMANY
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
80
(1) PRALSETINIB (S)

(2) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(3) AZITHROMYCIN (T)
Dose interrupted
positive
N/A
Recovered/Resolve
d
2724343
75
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
995
(1) PRALSETINIB (S)

(2) FOSFOMYCIN TROMETAMOL (C)

(3) PIPERACILLIN (T)

(4) CIPROFLOXACIN (T)

(5) METHENAMINE HIPPURATE (T)

(6) ASCORBIC ACID (T)
Dose interrupted
positive
N/A
Recovered/Resolve
d
2725078
42
Male
GERMANY
Clinical Study
Healthcare
professional
Pneumonia
bacterial
Grade 3
32
(1) PRALSETINIB (S)

(2) COLECALCIFEROL (C)

(3) METOPROLOL (C)

(4) CALCIUM (C)

(5) AMOXICILLIN\CLAVULANIC ACID (T)

(6) CLARITHROMYCIN (T)

(7) AMPICILLIN SODIUM\SULBACTAM SODIUM (T)

N/A
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(8) METAMIZOLE (T)

(9) LEVOTHYROXINE (T)

(10) CALCITRIOL (T)
2725485
78
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
441
(1) PRALSETINIB (S)

(2) CEFPODOXIME (T)
Drug withdrawn
Negative
N/A
Not Recovered/Not
Resolved/Ongoing
2726036
67
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Clostridium
difficile colitis

Pseudomembran
ous colitis

Urinary tract
infection bacterial
Grade 3

Grade 3

Grade 3
752

752

752
(1) PRALSETINIB (S)

(2) MELATONIN (C)

(3) DIPHENHYDRAMINE (C)

(4) DOCUSATE SODIUM (C)

(5) LEVOTHYROXINE (C)

(6) ONDANSETRON (C)

(7) CETIRIZINE (C)

(8) OMEPRAZOLE (C)

(9) OMEPRAZOLE (C)

(10) DICLOFENAC SODIUM (C)

(11) FIDAXOMICIN (C)
Dose interrupted

Dose interrupted

Dose interrupted
NA

Positive

Positive
NA

Positive

Positive
Unknown

Recovered/Resolve
d


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(12) METRONIDAZOLE (C)

(13) LEVOFLOXACIN (C)

(14) CEFEPIME (C)

(15) BEZLOTOXUMAB (C)

(16) VANCOMYCIN (T)

(17) METRONIDAZOLE (T)
Recovered/Resolve
d
2726273
73
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Sepsis

Urinary tract
infection
Grade 4

Grade 3
267

267
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) CETIRIZINE (C)

(4) ESOMEPRAZOLE (C)

(5) IBUPROFEN (C)

(6) SITAGLIPTIN (C)

(7) LEVOTHYROXINE (C)

(8) MAGNESIUM OXIDE (C)

(9) ROSUVASTATIN (C)

(10) SIMVASTATIN (C)

(11) TELMISARTAN (C)

Drug withdrawn

Drug withdrawn
Positive

Positive
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(12) METFORMIN HYDROCHLORIDE\SITAGLIPTIN
PHOSPHATE MONOHYDRATE (C)

(13) METFORMIN (C)

(14) CEFTRIAXONE (T)

(15) VANCOMYCIN (T)
2726810
78
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
609
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) PROMETHAZINE (C)

(4) COLECALCIFEROL (C)

(5) DOCUSATE SODIUM (C)

(6) PARACETAMOL (T)

(7) BENZONATATE (T)

(8) DEXTROMETHORPHAN\GUAIFENESIN (T)

(9) PANTOPRAZOLE (T)

(10) DIPHENHYDRAMINE\HYDROCORTISONE\NYSTATIN
(T)

(11) DEXAMETHASONE (T)

(12) ONDANSETRON (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2726821
70
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
517
(1) PRALSETINIB (S)

(2) ALLOPURINOL (C)

(3) ATORVASTATIN (C)

(4) DULAGLUTIDE (C)

(5) INSULIN GLARGINE (C)

(6) COLECALCIFEROL (C)

(7) ACETYLSALICYLIC ACID (C)

(8) ZOLPIDEM (C)

(9) ALPRAZOLAM (C)

(10) HEPARIN (C)

(11) INSULIN LISPRO (C)

(12) LORAZEPAM (C)

(13) AZITHROMYCIN (C)

(14) PREDNISONE (C)
NR
Unknown
N/A
Recovered/Resolve
d
2729104
71
Male
UNITED STATES
OF AMERICA
Clinical Study
COVID-19
pneumonia
Grade 3
819
(1) PRALSETINIB (S)

(2) AMLODIPINE BESILATE (C)

(3) ACETYLSALICYLIC ACID (C)

(4) ATORVASTATIN CALCIUM (C)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

(5) UBIDECARENONE (C)

(6) FISH OIL (C)

(7) LEVOTHYROXINE SODIUM (C)

(8) VITAMIN B COMPLEX (C)
2729523
46
Male
CHINA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
218
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)
NR
Unknown
N/A
Not Recovered/Not
Resolved/Ongoing
2729531
55
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
13
(1) PRALSETINIB (S)

(2) OLMESARTAN MEDOXOMIL (C)

(3) INDAPAMIDE (C)

(4) AMLODIPINE BESILATE (C)

(5) METHYLPREDNISOLONE SODIUM SUCCINATE (C)

(6) RABEPRAZOLE SODIUM (C)

(7) TRAMADOL (C)

(8) CATEQUENTINIB (C)

(9) ZOLEDRONIC ACID (C)

(10) FUROSEMIDE (C)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(11) CALCIUM GLUCONATE (C)

(12) GLUCOSE (C)

(13) INSULIN NOS (C)
2733973
54
Female
ITALY
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
83
(1) PRALSETINIB (S)

(2) DEXAMETHASONE (C)

(3) COLECALCIFEROL (C)

(4) MAGNESIUM HYDROXIDE (C)

(5) ANASTROZOLE (C)

(6) LANSOPRAZOLE (C)

(7) CARVEDILOL (C)

(8) AMLODIPINE (C)

(9) AMBROXOL (C)

(10) DIHYDROCODEINE (C)

(11) AMILORIDE\HYDROCHLOROTHIAZIDE (C)

(12) LEVOFLOXACIN (T)

(13) HYDROCHLOROTHIAZIDE\IRBESARTAN (T)

(14) FLUORESCEIN (T)
Drug withdrawn
Positive
N/A
Recovered/Resolve
d With Sequelae

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(15) PARACETAMOL (T)
2734973
67
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Arthritis infective
Grade 3
609
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) AMOXICILLIN (C)

(4) MELOXICAM (C)

(5) METOPROLOL (C)

(6) OXYCODONE (C)

(7) METOPROLOL SUCCINATE (C)

(8) HYDROCHLOROTHIAZIDE (T)

(9) ACETYLSALICYLIC ACID (T)

(10) DOCUSATE SODIUM (T)

(11) FAMOTIDINE (T)

(12) SODIUM CHLORIDE (T)

(13) DIPHENHYDRAMINE (T)

(14) MORPHINE (T)

(15) NALOXONE (T)

(16) CEFEPIME (T)

Dose interrupted
positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(17) VANCOMYCIN (T)

(18) POTASSIUM CHLORIDE (T)
2737755
87
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
158
(1) PRALSETINIB (S)
N/A
N/A
N/A
Recovered/Resolve
d
2739010
61
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Herpes zoster
Grade 3
29
(1) PRALSETINIB (S)

(2) CALCIUM CHLORIDE\GLUCOSE\POTASSIUM
CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE (C)

(3) ARTEMISIA ARGYI (C)

(4) DICLOFENAC SODIUM (C)

(5) ACICLOVIR (T)

(6) GABAPENTIN (T)

(7) PARACETAMOL (T)

(8) CHLORPHENAMINE MALEATE (T)

(9) BROMELAINS (T)

(10) ACICLOVIR (T)

(11) CALAMINE (T)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(12) AMOXICILLIN SODIUM\CLAVULANATE POTASSIUM
(T)
2739673
75
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urosepsis
Grade 3
695
(1) PRALSETINIB (S)

(2) METHENAMINE HIPPURATE (C)

(3) ASCORBIC ACID (C)

(4) VANCOMYCIN (T)

(5) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(6) AMPICILLIN (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2740001
46
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pneumonia
cytomegaloviral
Grade 3
22
(1) PRALSETINIB (S)

(2) CALCIUM CITRATE\COLECALCIFEROL (C)

(3) CALCITRIOL (C)

(4) SILYBUM MARIANUM (C)

(5) MUPIROCIN (C)
NR
Unknown
N/A
Recovered/Resolve
d
2740296
54
Male
UNITED STATES
OF AMERICA
Non-Interventional
Study/Program
Healthcare
professional
Pneumonia
Grade 3
247
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) OXYCODONE HYDROCHLORIDE (C)

(4) VANCOMYCIN (C)

(5) CALCITRIOL (C)
NR
Unknown
N/A
Recovered/Resolve
d
2740809
62
Female
Upper respiratory
tract infection
Grade 3
136
(1) PRALSETINIB (S)

(2) CALCIUM (C)
Dose interrupted
Positive
Negative

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
CHINA
Clinical Study
Healthcare
professional

(3) LEVOFLOXACIN (C)

(4) ZINC GLUCONATE (C)

(5) AMBROXOL HYDROCHLORIDE (C)

(6) OMEPRAZOLE SODIUM (C)

(7) SODIUM CHLORIDE (C)

(8) DEXAMETHASONE SODIUM PHOSPHATE (C)

(9) CHYMOTRYPSIN (C)

(10) GENTAMICIN SULFATE (C)

(11) MEGESTROL (C)

(12) POTASSIUM CHLORIDE (C)

(13) METOCLOPRAMIDE (C)

(14) LANSOPRAZOLE (C)
Recovered/Resolve
d
2742023
59
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Hepatitis B
reactivation
Grade 3
88
(1) PRALSETINIB (S)

(2) URSODEOXYCHOLIC ACID (C)

(3) SILYBUM MARIANUM (C)

(4) ORNITHINE ASPARTATE (T)

(5) ENTECAVIR (T)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2744401
77
Female
TAIWAN,
PROVINCE OF
CHINA
Clinical Study
Healthcare
professional
Kidney infection

Urinary tract
infection
Grade 3

Grade 3
157

198
(1) PRALSETINIB (S)

(2) MAGNESIUM OXIDE (C)

(3) ZOLPIDEM TARTRATE (C)

(4) PARACETAMOL (C)

(5) BACLOFEN (C)

(6) PARACETAMOL\TRAMADOL HYDROCHLORIDE (C)

(7) AMLODIPINE BESILATE (C)

(8) DENOSUMAB (C)

(9) CEFTRIAXONE SODIUM (C)

(10) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (C)

(11) MEROPENEM (C)

(12) CEFTRIAXONE (C)

(13) FUROSEMIDE (C)

(14) POTASSIUM GLUCONATE (T)

(15) PROCHLORPERAZINE MALEATE (T)
Dose interrupted

Dose interrupted
Positive

N/A
N/A

N/A
Recovered/Resolve
d

Recovered/Resolve
d
2744633
31
Female
CHINA
Clinical Study
Gastroenteritis
Grade 3
326
(1) PRALSETINIB (S)

(2) PANTOPRAZOLE (T)

(3) MONTMORILLONITE (T)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional
2747622
67
Female
SINGAPORE
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
113
(1) PRALSETINIB (S)

(2) CODEINE PHOSPHATE (C)

(3) PREDNISOLONE (C)

(4) COLECALCIFEROL (C)

(5) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(6) DOXYCYCLINE (T)
Dose interrupted
Positive
Negative
Recovered/Resolve
d
2752277
32
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
325
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) CALCITRIOL (C)

(4) CALCIUM CITRATE\COLECALCIFEROL (C)

(5) COLECALCIFEROL (C)

(6) FLUDROCORTISONE (C)

(7) LEVOTHYROXINE (C)

(8) DOCUSATE SODIUM\SENNOSIDE A+B (C)

(9) DIPHENHYDRAMINE\LIDOCAINE (C)

(10) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(11) AMLODIPINE (C)
N/A
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(12) PREDNISONE (C)
2753217
56
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
171
(1) PRALSETINIB (S)

(2) NIFEDIPINE (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d
2753743
37
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
COVID-19
Grade 3
390
(1) PRALSETINIB (S)

(2) MORPHINE SULFATE (C)

(3) ONDANSETRON (C)

(4) SENNA SPP. (C)

(5) ZOLEDRONIC ACID (C)

(6) SALBUTAMOL (C)

(7) MACROGOL 3350 (C)

(8) POTASSIUM CHLORIDE (C)

(9) MAGNESIUM OXIDE (C)

(10) AZITHROMYCIN (T)

(11) DOXYCYCLINE (T)

(12) DEXAMETHASONE (T)

(13) CEFTRIAXONE (T)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(14) AMOXICILLIN (T)
2758001
72
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Sepsis
Grade 3
7
(1) PRALSETINIB (S)

(2) VALSARTAN (C)

(3) ATORVASTATIN CALCIUM (C)

(4) EDOXABAN TOSILATE (C)

(5) METOCLOPRAMIDE (C)

(6) MEGESTROL ACETATE (C)

(7) AMLODIPINE BESILATE (C)

(8) LEVOTHYROXINE SODIUM (C)

(9) ATENOLOL (C)

(10) PARACETAMOL\TRAMADOL HYDROCHLORIDE (C)

(11) AMINO ACIDS
NOS\CALCIUM\GLUCOSE\MAGNESIUM\POTASSIUM\SODI
UM (C)

(12) CHROMIC CHLORIDE\COPPER
SULFATE\MANGANESE SULFATE\ZINC SULFATE (C)

(13) BENZYDAMINE HYDROCHLORIDE (C)

(14) SODIUM BICARBONATE (C)

(15) PARACETAMOL (C)
Dose interrupted
Positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(16) URSODEOXYCHOLIC ACID (C)

(17) MOXIFLOXACIN HYDROCHLORIDE (C)

(18) ALMAGATE (C)

(19) ACETYLSALICYLIC ACID (C)

(20) LORAZEPAM (C)

(21) MUPIROCIN (C)

(22) CARVEDILOL (C)

(23) FERROUS SULFATE (C)

(24) ADENINE HYDROCHLORIDE\BIFENDATE\CARNITINE
OROTATE\CYANOCOBALAMIN\LIVER\PYRIDOXINE
HYDROCHLORIDE\RIBOFLAVIN (C)

(25) LOPERAMIDE (C)

(26) ACETYLCYSTEINE (C)

(27) ALBUMIN HUMAN (C)

(28) FAMOTIDINE (C)

(29) HEPARIN (C)

(30) POTASSIUM CHLORIDE (C)

(31) FUROSEMIDE (C)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(32) ESOMEPRAZOLE (C)

(33) CHLORPHENAMINE MALEATE (C)

(34) SIMETICONE (C)

(35) PARACETAMOL (C)

(36) QUETIAPINE FUMARATE (C)

(37) ALANINE\ARGININE\CALCIUM CHLORIDE
DIHYDRATE\FISH OIL\GLUCOSE
MONOHYDRATE\GLYCINE\GLYCINE MAX
OIL\HISTIDINE\ISOLEUCINE\LEUCINE\LYSINE
HYDROCHLORIDE\MAGNESIUM SULFATE
HEPTAHYDRATE\MEDIUM-CHAIN
TRIGLYCERIDES\METHIONINE\OLEA EUROPAEA
OIL\PHENYLALANINE\POTASSIUM
CHLORIDE\PROLINE\SERINE\SODIUM ACETATE
TRIHYDRATE\SODIUM
GLYCEROPHOSPHATE\THREONINE\TRYPTOPHAN\TYRO
SINE\VALINE\ZINC SULFATE HEPTAHYDRATE (C)

(38) FLUCONAZOLE (T)

(39) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
2758033
42
Female
TAIWAN,
PROVINCE OF
CHINA
Non-Interventional
Pneumonia
aspiration
Grade 3
27
(1) PRALSETINIB (S)

(2) OSIMERTINIB (C)

(3) GEFITINIB (C)

(4) MEROPENEM (T)
Dose interrupted
Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Study/Program
Healthcare
professional

(5) LEVOFLOXACIN (T)
2758483
62
Male
FRANCE
Non-Interventional
Study/Program
Healthcare
professional
Pneumocystis
jirovecii infection
Grade 3
35
(1) PRALSETINIB (S)

(2) CALCIUM (C)

(3) PREDNISOLONE (C)
NR
Unknown
N/A
Recovered/Resolve
d
2758803
69
Female
GERMANY
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
154
(1) PRALSETINIB (S)

(2) CEFTRIAXONE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d
2761086
70
Female
GERMANY
Clinical Study
Healthcare
professional
COVID-19
pneumonia
Grade 3
254
(1) PRALSETINIB (S)

(2) RIVAROXABAN (C)

(3) HYDROCHLOROTHIAZIDE (C)

(4) POTASSIUM IODIDE (C)

(5) FOLIC ACID (C)
NR
Unknown
N/A
Recovered/Resolve
d
2761624
79
Female
GERMANY
Non-Interventional
Study/Program
Pneumonia
Grade 3
32
(1) PRALSETINIB (S)

(2) DEXPANTHENOL (C)

(3) BISOPROLOL (C)

(4) LISINOPRIL (C)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

(5) ACETYLSALICYLIC ACID (C)

(6) ATORVASTATIN (C)

(7) LEVOTHYROXINE SODIUM (C)

(8) PANTOPRAZOLE (C)

(9) PIPERACILLIN\TAZOBACTAM (T)
2777286
70
Female
CHINA
Clinical Study
Healthcare
professional
Bacteraemia
Grade 3
146
(1) PRALSETINIB (S)

(2) CEFTRIAXONE SODIUM (T)
Dose interrupted
Positive
Negative
Recovered/Resolve
d
2788575
53
Female
GERMANY
Clinical Study
Healthcare
professional
Herpes zoster
Grade 3
261
(1) PRALSETINIB (S)

(2) ACICLOVIR (C)

(3) ACICLOVIR (T)

(4) PREGABALIN (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d With Sequelae
2791037
71
Female
ITALY
Clinical Study
Healthcare
professional
Urosepsis
Grade 3
26
(1) PRALSETINIB (S)

(2) DENOSUMAB (C)

(3) NALOXONE HYDROCHLORIDE\OXYCODONE
HYDROCHLORIDE (C)

(4) PARACETAMOL (C)

(5) PREGABALIN (C)
Drug withdrawn
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(6) RANITIDINE (C)

(7) METOPROLOL (C)

(8) ROSUVASTATIN (C)

(9) CLOPIDOGREL (C)

(10) EDOXABAN (C)

(11) DOXAZOSIN MESILATE (C)

(12) CALCIUM (C)

(13) FERROUS SULFATE (C)

(14) ALLOPURINOL (C)

(15) COLECALCIFEROL (C)

(16) BROMAZEPAM (C)

(17) AMLODIPINE (C)

(18) MICONAZOLE (C)

(19) CLOTRIMAZOLE (C)

(20) CEFTRIAXONE (T)
2791289
71
Male
UNITED STATES
Diverticulitis
Grade 3
352
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

Dose interrupted
Positive
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
OF AMERICA
Clinical Study
Healthcare
professional
(3) CALCITRIOL (C)

(4) ALFUZOSIN (C)

(5) CALCIUM CARBONATE\COLECALCIFEROL (C)

(6) MONTELUKAST SODIUM (C)

(7) PITAVASTATIN CALCIUM (C)

(8) ESOMEPRAZOLE (C)

(9) CIPROFLOXACIN (T)

(10) METRONIDAZOLE (T)

(11) SODIUM CHLORIDE (T)
Recovered/Resolve
d
2791328
69
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Enterococcal
bacteraemia
Grade 3
6
(1) PRALSETINIB (S)

(2) GLUCOSE\SODIUM CHLORIDE (C)

(3) SODIUM CHLORIDE (C)

(4) DEXAMETHASONE (C)

(5) ENOXAPARIN (C)

(6) HYDROCHLOROTHIAZIDE\LISINOPRIL DIHYDRATE (C)

(7) PANTOPRAZOLE (C)

(8) PARACETAMOL (C)

(9) LORAZEPAM (C)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(10) SENNOSIDE A+B (C)

(11) DALTEPARIN SODIUM (C)

(12) HYDROCHLOROTHIAZIDE\LISINOPRIL (C)

(13) OMEPRAZOLE (C)

(14) OXYGEN (C)

(15) PROCHLORPERAZINE EDISYLATE (C)

(16) VANCOMYCIN (T)

(17) CEFEPIME (T)
2791662
60
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Skin infection
Grade 3
672
(1) PRALSETINIB (S)

(2) ACETYLSALICYLIC ACID (C)

(3) COLECALCIFEROL (C)

(4) FLUTICASONE (C)

(5) OMEPRAZOLE (C)

(6) LISINOPRIL (C)

(7) BENZONATATE (C)

(8) CODEINE PHOSPHATE\GUAIFENESIN (C)

(9) HYDROCODONE BITARTRATE\PARACETAMOL (C)

Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(10) CEFALEXIN (T)

(11) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)
2791862
72
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Diverticulitis
intestinal
perforated
Grade 3
204
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) ONDANSETRON (C)

(4) PANTOPRAZOLE (C)

(5) TADALAFIL (C)

(6) CETIRIZINE HYDROCHLORIDE (C)

(7) FEXOFENADINE HYDROCHLORIDE (C)

(8) TERBINAFINE (C)

(9) XYLITOL (C)

(10) TAMSULOSIN (C)

(11) AMLODIPINE (C)

(12) ROSUVASTATIN (C)

(13) ACETYLSALICYLIC ACID (C)

(14) MELOXICAM (C)

(15) OXYCODONE (C)

(16) METRONIDAZOLE (T)
Dose interrupted
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(17) CEFTRIAXONE (T)

(18) ENOXAPARIN (T)

(19) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(20) AMOXICILLIN\CLAVULANATE POTASSIUM (T)
2792158
60
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
20
(1) PRALSETINIB (S)

(2) ATENOLOL (C)

(3) CLONAZEPAM (C)

(4) ERGOCALCIFEROL (C)

(5) FAMOTIDINE (C)

(6) FUROSEMIDE (C)

(7) HYDROMORPHONE HYDROCHLORIDE (C)

(8) LEVOTHYROXINE SODIUM (C)

(9) METHADONE HYDROCHLORIDE (C)

(10) NYSTATIN (C)

(11) GLYCERYL TRINITRATE (C)

(12) ONDANSETRON (C)

(13) QUETIAPINE FUMARATE (C)

NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(14) HYDROCHLOROTHIAZIDE\TRIAMTERENE (C)

(15) SALBUTAMOL SULFATE (C)

(16) CEFEPIME (C)

(17) DEXAMETHASONE (C)

(18) DOCUSATE SODIUM (C)

(19) HYDROMORPHONE HYDROCHLORIDE (C)

(20) NALOXONE HYDROCHLORIDE (C)

(21) SENNOSIDE A+B (C)

(22) TRIAMCINOLONE ACETONIDE (C)

(23) CEFPODOXIME PROXETIL (C)

(24) LEVOFLOXACIN (C)

(25) SODIUM CHLORIDE (T)

(26) CEFEPIME HYDROCHLORIDE (T)

(27) AMOXICILLIN\CLAVULANATE POTASSIUM (T)
2792160
75
Male
UNITED
KINGDOM
Clinical Study
Urinary tract
infection
Grade 3
16
(1) PRALSETINIB (S)

(2) ZOPICLONE (C)

(3) ALFACALCIDOL (C)

(4) BISOPROLOL (C)
Drug withdrawn
Positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

(5) LEVOTHYROXINE (C)

(6) BICALUTAMIDE (C)

(7) TAMOXIFEN (C)

(8) LOPERAMIDE (C)

(9) NITROFURANTOIN (T)
2792192
69
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
101
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) LORAZEPAM (C)

(4) BROMAZEPAM (C)

(5) LOPERAMIDE (C)

(6) RANITIDINE (C)

(7) TIROPRAMIDE HYDROCHLORIDE (C)

(8) CHLORPHENAMINE MALEATE (C)

(9) CIPROFLOXACIN (T)

(10) CEFOTAXIME (T)

(11) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(12) CEFIXIME (T)
N/A
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2792250
69
Female
CHINA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
290
(1) PRALSETINIB (S)

(2) ATORVASTATIN CALCIUM (C)

(3) BISOPROLOL FUMARATE (C)

(4) GLICLAZIDE (C)

(5) NIFEDIPINE (C)

(6) ZOLPIDEM TARTRATE (C)

(7) GLUTATHIONE SODIUM (C)

(8) POLYENE PHOSPHATIDYLCHOLINE (C)
Dose interrupted
positive
N/A
Recovered/Resolve
d
2792290
70
Male
SPAIN
Clinical Study
Healthcare
professional
Sepsis
Grade 3
103
(1) PRALSETINIB (S)

(2) VERAPAMIL HYDROCHLORIDE (C)

(3) PARACETAMOL (C)

(4) OMEPRAZOLE (C)

(5) METOCLOPRAMIDE (C)

(6) ENOXAPARIN (C)

(7) CEFTRIAXONE (T)

(8) MEROPENEM (T)

(9) VANCOMYCIN (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2792649
51
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pyelonephritis
acute
Grade 3
142
(1) PRALSETINIB (S)

(2) ISOSORBIDE MONONITRATE (C)

(3) CILAZAPRIL (C)

(4) MAGNESIUM OXIDE (C)

(5) AMMONIUM CHLORIDE\CHLORPHENAMINE
MALEATE\DIHYDROCODEINE
BITARTRATE\METHYLEPHEDRINE HYDROCHLORIDE-DL
(C)

(6) BISACODYL (C)

(7) LACTULOSE (C)

(8) TETRACOSACTIDE ACETATE (C)

(9) MEROPENEM TRIHYDRATE (T)

(10) CEFTRIAXONE SODIUM (T)

(11) CIPROFLOXACIN (T)
Dose interrupted
Positive
N/A

Recovered/Resolve
d With Sequelae
2792701
76
Male
NETHERLANDS
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
57
(1) PRALSETINIB (S)

(2) SIMVASTATIN (C)

(3) FOLIC ACID (C)

(4) DEXAMETHASONE (C)

(5) SULFAMETHOXAZOLE\TRIMETHOPRIM (C)

NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(6) CYANOCOBALAMIN (C)

(7) RISEDRONIC ACID (C)

(8) CEFUROXIME (T)
2792727
60
Female
FRANCE
Clinical Study
Healthcare
professional
Bronchitis
Grade 3
38
(1) PRALSETINIB (S)

(2) FUROSEMIDE (C)

(3) BISOPROLOL FUMARATE (C)

(4) ATORVASTATIN CALCIUM (C)

(5) ACETYLSALICYLATE LYSINE (C)

(6) POTASSIUM CHLORIDE (C)

(7) PARACETAMOL (C)

(8) METOCLOPRAMIDE HYDROCHLORIDE (C)

(9) AMOXICILLIN\CLAVULANATE POTASSIUM (T)
NR
Unknown
N/A
Recovered/Resolve
d
2792736
82
Male
SINGAPORE
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
26
(1) PRALSETINIB (S)

(2) AMLODIPINE (C)

(3) SIMVASTATIN (C)

(4) LACTULOSE (C)

(5) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(6) OSELTAMIVIR PHOSPHATE (T)
Dose interrupted
positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(7) AZITHROMYCIN (T)
2793034
67
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Pneumocystis
jirovecii
pneumonia
Grade 3
306
(1) PRALSETINIB (S)

(2) RIVAROXABAN (C)

(3) LORAZEPAM (C)

(4) SALBUTAMOL SULFATE (C)

(5) CODEINE
PHOSPHATE\GUAIFENESIN\PSEUDOEPHEDRINE
HYDROCHLORIDE (C)

(6) FLUDROCORTISONE ACETATE (C)

(7) FLUTICASONE PROPIONATE (C)

(8) HYDROCORTISONE (C)

(9) FENOTEROL HYDROBROMIDE\IPRATROPIUM
BROMIDE (C)

(10) FORMOTEROL FUMARATE\MOMETASONE FUROATE
(C)

(11) MONTELUKAST SODIUM (C)

(12) PANTOPRAZOLE SODIUM SESQUIHYDRATE (C)

(13) RIVAROXABAN (C)

(14) LEVOTHYROXINE SODIUM (C)

Dose interrupted
positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(15) TOPIRAMATE (C)

(16) GUAIFENESIN\PSEUDOEPHEDRINE
HYDROCHLORIDE (C)

(17) GABAPENTIN (C)

(18) MACROGOL 3350 (C)

(19) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(20) MELATONIN (C)

(21) MACROGOL\PROPYLENE
GLYCOL\SIMETICONE\SORBIC ACID\SORBITOL\WHITE
SOFT PARAFFIN (C)
2793454
46
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Diverticulitis
Grade 3
51
(1) PRALSETINIB (S)

(2) ENOXAPARIN SODIUM (C)

(3) AMLODIPINE BESILATE (C)

(4) CETIRIZINE HYDROCHLORIDE (C)

(5) FLUTICASONE PROPIONATE (C)

(6) SILYBUM MARIANUM (C)

(7) FISH OIL (C)

(8) PLANTAGO OVATA (C)

(9) POTASSIUM PHOSPHATE MONOBASIC\SODIUM
PHOSPHATE DIBASIC\SODIUM PHOSPHATE MONOBASIC
Dose interrupted
positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(ANHYDROUS) (C)

(10) TRAZODONE HYDROCHLORIDE (C)

(11) METRONIDAZOLE (T)

(12) CEFTRIAXONE SODIUM (T)

(13) METRONIDAZOLE (T)

(14) MORPHINE (T)

(15) AMOXICILLIN\CLAVULANATE POTASSIUM (T)

(16) CEFEPIME (T)

(17) VANCOMYCIN (T)

(18) CEFTRIAXONE (T)

(19) CEFUROXIME AXETIL (T)
2793490
46
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Scrotal cellulitis
Grade 3
58
(1) PRALSETINIB (S)

(2) OMEPRAZOLE (C)

(3) ATORVASTATIN CALCIUM (C)

(4) VENLAFAXINE (C)

(5) WARFARIN (C)

(6) COLECALCIFEROL (C)

(7) BISOPROLOL FUMARATE (C)
Dose not changed
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(8) LEVOTHYROXINE (C)

(9) MIRTAZAPINE (C)

(10) ZOLEDRONIC ACID MONOHYDRATE (C)

(11) LISINOPRIL (C)

(12) SALBUTAMOL (C)

(13) FUROSEMIDE (C)

(14) MACROGOL 3350 (C)

(15) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(16) CALCIUM\MAGNESIUM\ZINC (C)

(17) PARACETAMOL (T)

(18) CEFTRIAXONE SODIUM (T)

(19) MORPHINE (T)

(20) WARFARIN SODIUM (T)

(21) METOCLOPRAMIDE HYDROCHLORIDE (T)

(22) ALUMINIUM HYDROXIDE\MAGNESIUM
HYDROXIDE\SIMETICONE (T)

(23) NALOXONE HYDROCHLORIDE (T)


AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(24) ONDANSETRON (T)

(25) AMOXICILLIN\CLAVULANATE POTASSIUM (T)
2793522
48
Female
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
136
(1) PRALSETINIB (S)

(2) ACECLOFENAC (C)

(3) FAMOTIDINE (C)

(4) THEOBROMINE (C)

(5) AMBROXOL (C)

(6) MOXIFLOXACIN (C)

(7) OXYCODONE (C)

(8) MORPHINE (C)

(9) MAGNESIUM OXIDE (C)

(10) MEGESTROL (C)

(11) TRAMADOL (C)

(12) GEMCITABINE (C)

(13) CARBOPLATIN (C)

(14) SITRAVATINIB (C)

(15) METOCLOPRAMIDE HYDROCHLORIDE (T)

(16) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)
N/A
N/A
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(17) LEVOFLOXACIN (T)

(18) MEROPENEM TRIHYDRATE (T)
2794773
58
Male
SINGAPORE
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
270
(1) PRALSETINIB (S)

(2) ACETYLSALICYLIC ACID (C)

(3) ATORVASTATIN (C)

(4) BISOPROLOL (C)

(5) NIFEDIPINE (C)

(6) FAMOTIDINE (C)

(7) LEVETIRACETAM (C)

(8) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(9) DEXAMETHASONE (T)

(10) VALPROATE SODIUM (T)

(11) AMOXICILLIN\CLAVULANATE POTASSIUM (T)

(12) DEXAMETHASONE PHOSPHATE (T)
NR
Unknown
N/A
Recovered/Resolve
d
2794779
49
Male
UNITED STATES
OF AMERICA
Clinical Study
Pneumonia
Grade 3
117
(1) PRALSETINIB (S)

(2) TAMSULOSIN (C)

(3) LEVOTHYROXINE (C)

(4) MIDODRINE (C)
Dose interrupted
positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional

(5) CALCIUM CITRATE\COLECALCIFEROL (C)

(6) FINASTERIDE (C)

(7) OXYCODONE (C)

(8) POTASSIUM CHLORIDE (C)

(9) PROCHLORPERAZINE (C)

(10) ONDANSETRON (C)

(11) FAMOTIDINE (C)

(12) CALCITRIOL (C)

(13) DILTIAZEM (C)
2794784
70
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
9
(1) PRALSETINIB (S)

(2) BACLOFEN (C)

(3) LEVETIRACETAM (C)

(4) LEVOTHYROXINE (C)

(5) DOCUSATE SODIUM (C)

(6) NITROFURANTOIN (C)

(7) BISACODYL (C)

(8) ERGOCALCIFEROL (C)

Dose interrupted
positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(9) MAGNESIUM HYDROXIDE (C)

(10) IBUPROFEN (C)

(11) SENNA SPP. (C)

(12) OXYCODONE (C)

(13) MACROGOL (C)

(14) DOCUSATE SODIUM\SENNOSIDE A+B (C)

(15) ENOXAPARIN (C)

(16) PANTOPRAZOLE (C)

(17) CEFTRIAXONE (T)

(18) AZITHROMYCIN (T)

(19) PARACETAMOL (T)
2794879
25
Female
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Osteomyelitis
Grade 3
351
(1) PRALSETINIB (S)

(2) HYDROCHLOROTHIAZIDE (C)

(3) ONDANSETRON (C)

(4) CARVEDILOL (C)

(5) HYDRALAZINE HYDROCHLORIDE (C)

(6) AMLODIPINE BESILATE (C)

(7) CALCIUM CARBONATE (C)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(8) ESOMEPRAZOLE (C)

(9) TRAMADOL (C)

(10) CALCITRIOL (C)

(11) SOLIFENACIN SUCCINATE (C)

(12) OLANZAPINE (C)

(13) MELATONIN (C)

(14) LORAZEPAM (C)

(15) ESCITALOPRAM OXALATE (C)

(16) LEVOTHYROXINE SODIUM (C)

(17) PREDNISONE (C)

(18) PROMETHAZINE (C)

(19) METHYLPREDNISOLONE (C)

(20) LEVOFLOXACIN (C)
2795146
51
Female
ITALY
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
77
(1) PRALSETINIB (S)

(2) RANITIDINE (C)

(3) DELORAZEPAM (C)

(4) CALCIUM CARBONATE (C)

Dose interrupted
positive
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(5) ARNICA MONTANA (C)

(6) LACTOBACILLUS ACIDOPHILUS (C)

(7) BUPRENORPHINE (C)

(8) ZOLEDRONIC ACID (C)

(9) DIHYDROCODEINE (C)

(10) RAMIPRIL (C)

(11) POTASSIUM CHLORIDE (C)

(12) CALCIUM CARBONATE (C)

(13) PARACETAMOL (C)

(14) LEVOFLOXACIN (T)

(15) OXYGEN (T)

(16) CEFTRIAXONE (T)

(17) PIPERACILLIN\TAZOBACTAM (T)

(18) SULFAMETHOXAZOLE\TRIMETHOPRIM (T)

(19) METHYLPREDNISOLONE (T)
2795155
56
Male
UNITED STATES
OF AMERICA
Pneumonia
Grade 3
77
(1) PRALSETINIB (S)

(2) ATORVASTATIN CALCIUM (C)

(3) FOLIC ACID (C)
NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional

(4) ACETYLSALICYLIC ACID (C)

(5) CYANOCOBALAMIN (C)

(6) FLUDROCORTISONE ACETATE (C)

(7) GABAPENTIN (C)

(8) LEVOTHYROXINE SODIUM (C)

(9) SERTRALINE HYDROCHLORIDE (C)

(10) SILDENAFIL CITRATE (C)

(11) CALCIUM (C)

(12) ZINC (C)

(13) MAGNESIUM (C)

(14) CETIRIZINE HYDROCHLORIDE (C)
2796670
64
Female
FRANCE
Clinical Study
Healthcare
professional
Clostridium
difficile colitis
Grade 3
156
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) AMLODIPINE (C)

(4) DENOSUMAB (C)

(5) AMOXICILLIN\CLAVULANATE POTASSIUM (C)

(6) CEFTRIAXONE SODIUM (T)

NR
Unknown
N/A
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(7) METRONIDAZOLE (T)

(8) OFLOXACIN (T)
2797009
65
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Cellulitis
Grade 3
208
(1) PRALSETINIB (S)

(2) APIXABAN (C)

(3) NIFEDIPINE (C)

(4) TAMSULOSIN HYDROCHLORIDE (C)

(5) VANCOMYCIN (T)

(6) SODIUM CHLORIDE (T)

(7) MINOCYCLINE (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2797651
44
Female
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Pneumonia
Grade 3
130
(1) PRALSETINIB (S)

(2) AZITHROMYCIN (T)

(3) CEFTRIAXONE (T)

(4) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(5) DOXYCYCLINE (T)

(6) FILGRASTIM (T)

(7) AMOXICILLIN\CLAVULANATE POTASSIUM (T)
Dose interrupted
positive
Unknown
Recovered/Resolve
d
2797985
53
Male
KOREA,
REPUBLIC OF
Epididymitis
Grade 3
95
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM (C)

(3) TRAMADOL (C)
Dose interrupted


Positive
Negative

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional

(4) CALCIUM\COLECALCIFEROL\MAGNESIUM (C)

(5) CODEINE (C)

(6) LACTULOSE (C)

(7) FAMOTIDINE (C)

(8) CHLORPHENAMINE MALEATE (C)

(9) CALCIUM CARBONATE\MAGNESIUM
CARBONATE\MAGNESIUM HYDROXIDE\MAGNESIUM
TRISILICATE (C)

(10) LEVOTHYROXINE (C)

(11) CEFTRIAXONE (C)

(12) CEFIXIME (C)

(13) ACECLOFENAC (C)

(14) PROPACETAMOL (C)

(15) PIPERACILLIN SODIUM\TAZOBACTAM SODIUM (T)

(16) AMOXICILLIN TRIHYDRATE\CLAVULANATE
POTASSIUM (T)
Recovered/Resolve
d With Sequelae
2798031
69
Female
UNITED STATES
OF AMERICA
Bacteraemia
Grade 3
85
(1) PRALSETINIB (S)

(2) ATORVASTATIN CALCIUM (C)

(3) DULAGLUTIDE (C)
Dose interrupted


Positive
Unknown

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare
professional

(4) INSULIN GLARGINE (C)

(5) INSULIN LISPRO (C)

(6) INSULIN GLARGINE (C)

(7) FISH OIL (C)

(8) HEPARIN (C)

(9) ALLOPURINOL (C)

(10) COLECALCIFEROL (C)

(11) ACETYLSALICYLIC ACID (C)

(12) ZOLPIDEM (C)

(13) ALPRAZOLAM (C)

(14) POTASSIUM PHOSPHATE (T)

(15) VANCOMYCIN (T)

(16) AMPICILLIN (T)

(17) PARACETAMOL (T)
Recovered/Resolve
d
2798108
68
Male
UNITED STATES
OF AMERICA
Clinical Study
Bacteraemia

Sepsis
Grade 3

Grade 3
923

923
(1) PRALSETINIB (S)

(2) DIPHENHYDRAMINE HYDROCHLORIDE (C)

(3) LEVOTHYROXINE SODIUM (C)

Dose interrupted

Dose interrupted


Positive

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Healthcare
professional
(4) LOPERAMIDE HYDROCHLORIDE (C)

(5) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(6) PREDNISONE (C)

(7) SENNA SPP. (C)

(8) CEFAZOLIN (T)

(9) CEFEPIME (T)

Positive
Negative

Negative
Recovered/Resolve
d

Recovered/Resolve
d
2798334
46
Male
UNITED STATES
OF AMERICA
Clinical Study
Non-healthcare
professional
Pneumonia
staphylococcal
Grade 3
29
(1) PRALSETINIB (S)

(2) OMEPRAZOLE (C)

(3) ATORVASTATIN CALCIUM (C)

(4) WARFARIN (C)

(5) COLECALCIFEROL (C)

(6) BISOPROLOL FUMARATE (C)

(7) LEVOTHYROXINE (C)

(8) MIRTAZAPINE (C)

(9) ZOLEDRONIC ACID MONOHYDRATE (C)

(10) LISINOPRIL (C)

(11) SALBUTAMOL (C)

(12) FUROSEMIDE (C)
Dose interrupted


Positive
Negative
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(13) MACROGOL 3350 (C)

(14) HYDROCODONE BITARTRATE\PARACETAMOL (C)

(15) AMINOSALICYLATE CALCIUM (C)

(16) ZINC (C)

(17) POTASSIUM CHLORIDE (C)

(18) ALUMINIUM HYDROXIDE\MAGNESIUM HYDROXIDE
(C)

(19) OXYGEN (C)

(20) SUNITINIB MALATE (C)

(21) ALUMINIUM HYDROXIDE\MAGNESIUM
HYDROXIDE\SIMETICONE (C)

(22) CEFTRIAXONE SODIUM (T)

(23) VANCOMYCIN (T)

(24) CEFEPIME HYDROCHLORIDE (T)

(25) AZITHROMYCIN (T)

(26) DOXYCYCLINE HYCLATE (T)

(27) PARACETAMOL (T)

(28) SODIUM CHLORIDE (T)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2798372
87
Male
UNITED STATES
OF AMERICA
Clinical Study
Healthcare
professional
Device related
infection
Grade 3
117
(1) PRALSETINIB (S)

(2) ASCORBIC ACID (C)

(3) COLECALCIFEROL (C)

(4) DILTIAZEM (C)

(5) DIGOXIN (C)

(6) SODIUM CHLORIDE (C)

(7) FINASTERIDE (C)

(8) PARACETAMOL (C)

(9) SENNA ALEXANDRINA (C)

(10) APIXABAN (C)

(11) MAGNESIUM HYDROXIDE (C)

(12) CYANOCOBALAMIN (C)

(13) CEFTRIAXONE (T)
Dose not changed
N/A
N/A
Recovered/Resolve
d
2798495
81
Male
KOREA,
REPUBLIC OF
Clinical Study
Healthcare
professional
Urinary tract
infection
Grade 3
124
(1) PRALSETINIB (S)

(2) BISACODYL (C)

(3) AMLODIPINE BESILATE (C)

(4) METFORMIN (C)

(5) CALCIUM CARBONATE\COLECALCIFEROL (C)
Dose interrupted
positive
Unknown
Recovered/Resolve
d

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred
Term of Interest*
Severity Grade
Time To
Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(6) LEVOTHYROXINE SODIUM (C)

(7) MAGNESIUM OXIDE (C)

(8) MEGESTROL ACETATE (C)

(9) DEXAMETHASONE (C)

(10) URSODEOXYCHOLIC ACID (C)

(11) DICLOFENAC DEANOL (T)

(12) CEFTRIAXONE SODIUM SESQUATERHYDRATE (T)

(13) CEFPIRAMIDE SODIUM (T)

(14) PARACETAMOL (T)


Category C (N=40)
AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2800573
66
Female
UNITED STATES OF
AMERICA
Clinical Study
Non-healthcare
professional
Pneumonia
Grade 3
200
(1) PRALSETINIB (S)
Dose interrupted
Positive
Negative
Recovered/Resolved
2802047
63
Male
TAIWAN, PROVINCE OF
CHINA
Clinical Study
Non-healthcare
professional
Pneumonia klebsiella
Grade 3
641
(1) PRALSETINIB (S)
Dose interrupted
Positive
Negative
Recovered/Resolved
2974676
Not reported
Not reported
CHINA
Spontaneous
Non-healthcare
professional
Pneumonia legionella
Grade 3
NR
(1) PRALSETINIB (S)
NR
Unknown
N/A
Recovering/Resolving
3029413
63
Male
CHINA
Non-Interventional
Study/Program
Non-healthcare
professional
Pneumonia bacterial
Grade 3
112
(1) PRALSETINIB (S)
NR
Unknown
N/A
Unknown

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2904495
60
Male
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
COVID-19


Grade 3
1095
(1) PRALSETINIB (S)

(2) REMDESIVIR (T)

(3) TOCILIZUMAB (T)

(4) SALBUTAMOL (T)

(5) METHYLPREDNISOLONE
(T)

(6) HOMATROPINE
METHYLBROMIDE\HYDROCO
DONE BITARTRATE (T)

(7) COLECALCIFEROL (T)
Dose interrupted
Positive
N/A
Recovered/Resolved With
Sequelae
2932342
67
Male
SPAIN
Clinical Study
Healthcare professional
Cholecystitis infective
Grade 3
921
(1) PRALSETINIB (S)
Dose interrupted
Positive
Unknown
Recovered/Resolved
2960716
53
Male
CHINA
Clinical Study
Healthcare professional
Pneumonia
Grade 3
725
(1) PRALSETINIB (S)

(2) CEFIXIME (T)

(3) MECAMYLAMINE (T)

(4) IBUPROFEN (T)

(5) CEFOTAXIME SODIUM (T)

(6) ASCORBIC ACID (T)

Dose interrupted
Positive
Negative
Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(7) DEXAMETHASONE
SODIUM PHOSPHATE (T)

(8) CEFOPERAZONE
SODIUM\SULBACTAM
SODIUM (T)

(9) MOXIFLOXACIN
HYDROCHLORIDE (T)

(10) CEFOPERAZONE
SODIUM\SULBACTAM
SODIUM (T)
2993277
69
Male
KOREA, REPUBLIC OF
Clinical Study
Healthcare professional
Pneumonia influenzal
Grade 3
24
(1) PRALSETINIB (S)

(2) PIPERACILLIN
SODIUM\TAZOBACTAM
SODIUM (T)

(3) LEVOFLOXACIN (T)
Dose interrupted
Positive
Unknown
Recovered/Resolved
2998733
72
Female
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Urinary tract infection
Grade 3
149
(1) PRALSETINIB (S)

(2) VANCOMYCIN (T)
Dose interrupted
Positive
N/A
Recovered/Resolved
3038243
74
Male
IRELAND
Non-Interventional
Study/Program
COVID-19 pneumonia
Grade 3
665
(1) PRALSETINIB (S)
Dose interrupted
Positive
Unknown
Recovering/Resolving

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Non-healthcare
professional
3038751
32
Male
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
COVID-19
Grade 3
1825
(1) PRALSETINIB (S)

(2) AMOXICILLIN (T)
Dose interrupted
Positive
Negative
Recovered/Resolved
3094592
61
Male
KOREA, REPUBLIC OF
Clinical Study
Healthcare professional
Pneumonia
Grade 3
460
(1) PRALSETINIB (S)

(2) PIPERACILLIN
SODIUM\TAZOBACTAM
SODIUM (T)

(3) MOXIFLOXACIN
HYDROCHLORIDE (T)

(4) LEVOFLOXACIN (T)
Dose interrupted
Positive
Negative
Recovered/Resolved
3113090
74
Male
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Bacteraemia
Grade 3
1095
(1) PRALSETINIB (S)

(2) LINEZOLID (T)

(3) MEROPENEM (T)

(4) CEFAZOLIN (T)
Dose interrupted
Positive
N/A
Recovered/Resolved
3145942
68
Female
SWITZERLAND
Clinical Study
Healthcare professional
Herpes zoster
Grade 3
31
(1) PRALSETINIB (S)

(2) METAMIZOLE (C)

(3) MACROGOL (C)

(4) ONDANSETRON (C)

Dose interrupted
Positive
N/A
Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(5) DOMPERIDONE (C)

(6) BUTYLSCOPOLAMINE
BROMIDE (C)

(7) AMLODIPINE (C)

(8) OXYCODONE
HYDROCHLORIDE (T)

(9) PARACETAMOL (T)

(10) METAMIZOLE (T)

(11) LIDOCAINE (T)

(12) CAPSAICIN (T)
3208469
64
Male
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Pneumonia
Grade 3
1825
(1) PRALSETINIB (S)
NR
Unknown
N/A
Recovered/Resolved
3277606
54
Female
CHINA
Clinical Study
Healthcare professional
COVID-19
Grade 3
1121
(1) PRALSETINIB (S)

(2) IBUPROFEN (C)
Dose interrupted
Positive
N/A
Recovered/Resolved
3278393
71
Male
ITALY
Q fever
Grade 3
405
(1) PRALSETINIB (S)

(2) PIPERACILLIN
SODIUM\TAZOBACTAM
Dose interrupted
Positive
N/A
Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
Clinical Study
Healthcare professional
SODIUM (T)

(3) LINEZOLID (T)
3300876
80
Female
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Haemophilus infection
Grade 3
1095
(1) PRALSETINIB (S)
Dose interrupted
Positive
N/A
Recovered/Resolved With
Sequelae
3323385
61
Female
CHINA
Clinical Study
Healthcare professional
Gastroenteritis
Grade 3
838
(1) PRALSETINIB (S)

(2) FUROSEMIDE (C)

(3) ESOMEPRAZOLE
MAGNESIUM (T)

(4) PINAVERIUM BROMIDE (T)

(5) ESOMEPRAZOLE SODIUM
(T)

(6) PHLOROGLUCINOL (T)
Dose not changed
N/A
N/A
Recovered/Resolved
3330307
66
Male
ITALY
Clinical Study
Healthcare professional
Pneumonia

Pneumonia legionella

COVID-19 pneumonia
Grade 3

Grade 3

Grade 3
36

4

4
(1) PRALSETINIB (S)

(2) CEFTAROLINE FOSAMIL
(C)

(3) LEVOFLOXACIN (T)

(4) REMDESIVIR (T)
Dose interrupted

Dose interrupted

Dose interrupted
Negative

Positive

Positive
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

Unknown

Unknown
Not Recovered/Not
Resolved/Ongoing

Recovered/Resolved With
Sequelae

Recovered/Resolved
3336773
67
Male
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Bacteraemia
Grade 3
1460
(1) PRALSETINIB (S)

(2) CEFTRIAXONE (C)
Dose interrupted
Positive
Unknown
Recovered/Resolved
3365358
69
Male
SPAIN
Clinical Study
Healthcare professional
Meningitis bacterial
Grade 3
1825
(1) PRALSETINIB (S)
Dose interrupted
Positive
N/A
Recovered/Resolved
3386191
49
Male
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Varicella
Grade 3
1825
(1) PRALSETINIB (S)

(2) ACICLOVIR (C)
Dose interrupted
Positive
N/A
Recovered/Resolved
3393152
60
Male
Urinary tract infection
Grade 3
1095
(1) PRALSETINIB (S)

(2) CEFTRIAXONE (T)
NR
Unknown

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
SPAIN
Clinical Study
Healthcare professional

(3) PARACETAMOL (T)
N/A
Recovered/Resolved
3446811
54
Male
ITALY
Clinical Study
Healthcare professional
Urinary tract infection
Grade 3
567
(1) PRALSETINIB (S)

(2) ESOMEPRAZOLE (C)

(3) BISOPROLOL
FUMARATE\PERINDOPRIL
ARGININE (C)

(4) CEFTRIAXONE (T)

(5) AZITHROMYCIN (T)
Dose not changed
N/A
N/A
Recovering/Resolving
3447222
61
Female
CHINA
Clinical Study
Non-healthcare
professional
Pneumonia
Grade 3
1095
(1) PRALSETINIB (S)

(2) MOXIFLOXACIN
HYDROCHLORIDE (C)

(3) DOXYCYCLINE HYCLATE
(C)

(4) IBUPROFEN (C)
NR
Unknown
N/A
Recovered/Resolved With
Sequelae
3452720
72
Female
GERMANY
Clinical Study
Healthcare professional
Infection
Grade 3
1825
(1) PRALSETINIB (S)

(2) COLECALCIFEROL (C)

(3) VALSARTAN (C)

(4) AMLODIPINE (C)

(5) MOMETASONE FUROATE
(C)

Dose interrupted
Positive
N/A
Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(6) AMPICILLIN
SODIUM\SULBACTAM
SODIUM (T)

(7) AZITHROMYCIN (T)
3477682
54
Male
GERMANY
Clinical Study
Non-healthcare
professional
Respiratory tract
infection
Grade 3
1825
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM
(C)

(3) BISOPROLOL (C)

(4) LOPERAMIDE (C)

(5) RAMIPRIL (C)

(6) TAZOBACTAM (T)

(7) AMOXICILLIN
TRIHYDRATE\CLAVULANIC
ACID (T)
Dose not changed
N/A
N/A
Recovered/Resolved
3489069
55
Male
GERMANY
Clinical Study
Healthcare professional
Spontaneous bacterial
peritonitis
Grade 3
NR
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) BISOPROLOL (C)

(4) MEROPENEM (T)
Dose not changed
N/A
N/A
Recovered/Resolved
3509451
67
Female
KOREA, REPUBLIC OF
Clinical Study
Healthcare professional
Pneumonia

Pyelonephritis acute
Grade 3

Grade 3
24

24
(1) PRALSETINIB (S)

(2) PIPERACILLIN
SODIUM\TAZOBACTAM
SODIUM (T)

Dose interrupted

Dose interrupted
Positive

Positive

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(3) LEVOFLOXACIN (T)

(4) MEROPENEM (T)

(5)
SULFAMETHOXAZOLE\TRIME
THOPRIM (T)

(6) FUROSEMIDE (T)

(7) METHYLPREDNISOLONE
SODIUM SUCCINATE (T)


N/A

N/A
Recovered/Resolved

Recovered/Resolved
2717114
54
Male
UNITED STATES OF
AMERICA
Non-Interventional
Study/Program
Healthcare professional
Pharyngeal abscess
Grade 3
124
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE SODIUM
(C)

(3) CALCITRIOL (C)

(4) OXYCODONE
HYDROCHLORIDE (C)

(5) CODEINE
PHOSPHATE\GUAIFENESIN
(C)

(6) VANCOMYCIN (C)

(7) BENZONATATE (C)

(8) LEVOFLOXACIN (C)
Dose interrupted
Negative
N/A
Not Recovered/Not
Resolved/Ongoing
2721262
57
Female
Pneumonia
Grade 3
27
(1) PRALSETINIB (S)

Dose interrupted



AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
CHINA
Clinical Study
Healthcare professional
(2) OSELTAMIVIR
PHOSPHATE (T)
Positive
Positive
Recovered/Resolved
2721878
57
Female
CHINA
Clinical Study
Healthcare professional
Pneumonia
Grade 3
28
(1) PRALSETINIB (S)

(2) ACETYLCYSTEINE (T)

(3) AMBROXOL
HYDROCHLORIDE (T)

(4) METHYLPREDNISOLONE
SODIUM SUCCINATE (T)

(5) IMIPENEM (T)

(6) CILASTATIN SODIUM (T)

(7)
SULFAMETHOXAZOLE\TRIME
THOPRIM (T)
Dose interrupted
Positive
Unknown
Recovered/Resolved
2724735
59
Female
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Appendicitis
Grade 3
71
(1) PRALSETINIB (S)

(2) ONDANSETRON (C)

(3) PROCHLORPERAZINE (C)

(4) POTASSIUM PHOSPHATE
(C)

(5)
AMOXICILLIN\CLAVULANATE
POTASSIUM (C)

(6) VANCOMYCIN (T)
N/A
N/A
N/A
Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(7) CEFEPIME (T)

(8) METRONIDAZOLE (T)
2733259
62
Female
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Diverticulitis
Grade 3
450
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) ASCORBIC ACID (C)

(4) CETIRIZINE
HYDROCHLORIDE (C)

(5) LORAZEPAM (C)

(6) OMEPRAZOLE (C)

(7) CURCUMA LONGA (C)

(8) POTASSIUM GLUCONATE
(C)
Dose interrupted
Positive
N/A
Recovered/Resolved
2775469
53
Female
UNITED KINGDOM
Clinical Study
Healthcare professional
Urinary tract infection
Grade 3
766
(1) PRALSETINIB (S)
Dose not changed
N/A
N/A
Recovered/Resolved
2791119
52
Female
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Appendicitis
Grade 3
25
(1) PRALSETINIB (S)

(2) SENNA SPP. (C)
Dose interrupted
Positive
N/A
Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2794008
59
Male
UNITED STATES OF
AMERICA
Clinical Study
Non-healthcare
professional
Sepsis
Grade 3
266
(1) PRALSETINIB (S)

(2) KETOROLAC
TROMETHAMINE (C)

(3) PIPERACILLIN
SODIUM\TAZOBACTAM
SODIUM (T)
NR
Unknown
N/A
Recovered/Resolved
2794401
63
Female
UNITED STATES OF
AMERICA
Clinical Study
Healthcare professional
Sepsis

Pneumonia
Grade 3

Grade 3
20

43
(1) PRALSETINIB (S)

(2) PARACETAMOL (C)

(3) ACETYLSALICYLIC ACID
(C)

(4) ERGOCALCIFEROL (C)

(5) GABAPENTIN (C)

(6) LIDOCAINE (C)

(7) TIZANIDINE (C)

(8) ONDANSETRON (C)

(9) MACROGOL (C)

(10) OXYCODONE (C)

(11) PROCHLORPERAZINE (C)

(12) FLUTICASONE
FUROATE\VILANTEROL
TRIFENATATE (C)
NR

NR
Unknown

Unknown
N/A

N/A
Recovered/Resolved

Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term
of Interest*
Severity Grade
Time To Onset (in
Days)
Drug Type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(13) ATORVASTATIN (C)

(14) ENOXAPARIN (C)

(15) VANCOMYCIN (T)

(16) PIPERACILLIN (T)

(17) AZITHROMYCIN (T)

(18) MEROPENEM (T)

(19) BUDESONIDE (T)

(20) AMPICILLIN
SODIUM\SULBACTAM
SODIUM (T)

(21) LEVOFLOXACIN (T)
2796571
63
Female
CHINA
Clinical Study
Healthcare professional
Upper respiratory tract
infection


Grade 3
229
(1) PRALSETINIB (S)
Dose interrupted
positive
Unknown
Recovered/Resolved


78
Drug Safety Report No: 1132062
Appendix 7
Listings of Cases Lacking Information on Severity Grades
for Infection Events from the Company Safety Database (N=249)

Category B (N=26)
AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
2767869
43
Female
UNITED STATES OF
AMERICA
Spontaneous
Non-healthcare
professional
Post procedural infection
NR
NR
(1) PRALSETINIB (S)
Dose not changed
NA
NA
Not Resolved
2800655
68
Female
UNITED STATES OF
AMERICA
Clinical Study
Non-healthcare
professional
Pneumonia
NR
154
(1) PRALSETINIB (S)

(2) COLECALCIFEROL (C)

(3) FAMOTIDINE (C)

(4) LEVOTHYROXINE (C)

(5) MORPHINE (C)

(6) NAPROXEN (C)

(7) OXYCODONE (C)

(8) PROCHLORPERAZINE
(C)

(9) SENNOSIDE A+B (C)

(10) SALBUTAMOL (C)

(11) CANNABIDIOL (C)

(12) LORATADINE (C)
Drug withdrawn
NA
NA
Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(13) DOCUSATE SODIUM
(C)

(14) ROFLUMILAST (C)

(15) CICLESONIDE (C)

(16) TIOTROPIUM (C)

(17) MACROGOL 3350 (C)

(18) BENZOCAINE (C)

(19) FUROSEMIDE (C)

(20) POTASSIUM
CHLORIDE (C)

(21) PREDNISONE (C)

(22) LOPERAMIDE (C)

(23)
IPRATROPIUM\SALBUTA
MOL (C)

(24) OXYGEN (C)

(25)
METHYLPREDNISOLONE
SODIUM SUCCINATE (C)

(26) BENZOCAINE (C)

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome

(27)
PIPERACILLIN\TAZOBACT
AM (C)

(28) VANCOMYCIN (C)

(29) BENZONATATE (C)

(30) ENOXAPARIN
SODIUM (T)

(31) DOXYCYCLINE (T)

(32) LEVOFLOXACIN (T)

(33) CEFTRIAXONE (T)

(34) AZITHROMYCIN (T)

(35) PREDNISONE (T)

(36) METRONIDAZOLE (T)
2817246
Not reported
Female
UNITED STATES OF
AMERICA
Spontaneous
Non-healthcare
professional
Pneumonia
NR
NR
(1) PRALSETINIB (S)

(2) PREDNISONE (C)
Dose not changed
NA
NA
Resolved
2823365
34
Male
Oral infection
NR
78
(1) PRALSETINIB (S)
Dose interrupted
Negative
N/A

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
UNITED STATES OF
AMERICA
Spontaneous
Healthcare Professional
Not Recovered/Not
Resolved/Ongoing
2826988
77
Male
SWITZERLAND
Non-Interventional
Study/Program
Healthcare Professional
Pneumonia
NR
NR
(1) PRALSETINIB (S)

(2) TORASEMIDE (S)

(3) RIVAROXABAN (C)

(4) OLMESARTAN (C)

(5) AMLODIPINE (C)

(6) RIVAROXABAN (C)

(7) MOXIFLOXACIN (T)

(8) PIPERACILLIN
SODIUM\TAZOBACTAM
SODIUM (T)

(9) PREDNISOLONE (T)
Drug withdrawn
NA
NA
NR
2869377
53
Male
FRANCE
Non-Interventional
Study/Program
Healthcare Professional
Pneumonia


NR
NR
(1) PRALSETINIB (S)

(2) LEVOTHYROXINE (C)

(3) PREDNISOLONE (C)

(4) FOLIC ACID (C)

(5) ATORVASTATIN (C)

(6) CALCIUM
Drug withdrawn
NA
NA
 Recovering/Resolving

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
CARBONATE (C)

(7) PARACETAMOL (C)

(8) LACTULOSE (C)

(9) ESCITALOPRAM (C)

(10) GABAPENTIN (C)

(11) GLICLAZIDE (C)

(12) LEVOTHYROXINE (C)

(13) MACROGOL
3350\POTASSIUM
CHLORIDE\SODIUM
BICARBONATE\SODIUM
CHLORIDE (C)

(14) OXYCODONE (C)

(15) OXYCODONE
HYDROCHLORIDE (C)

(16) PANTOPRAZOLE (C)

(17) QUETIAPINE (C)

(18) OXAZEPAM (C)

(19) ALFACALCIDOL (C)

(20) COLECALCIFEROL

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
(C)

(21) CEFOTAXIME (C)

(22) INSULIN ASPART (C)

(23) ENOXAPARIN
SODIUM (C)

(24) SODIUM CHLORIDE
(C)

(25) HEPARIN (C)

(26) PIPERACILLIN
SODIUM\TAZOBACTAM
SODIUM (C)

(27)
METHYLPREDNISOLONE
SODIUM SUCCINATE (C)

(28) ESOMEPRAZOLE (C)
2901843
76
Male
JAPAN
Clinical Study
Healthcare Professional
Bacteraemia
NR
22
(1) PRALSETINIB (S)

(2) THYROID (C)

(3) CALCIUM
CARBONATE (C)

(4) ENALAPRIL MALEATE
(C)

(5) CLOBETASOL
Dose interrupted
Positive
NA
 Recovered/Resolved

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
PROPIONATE (C)

(6) HYDROCORTISONE
BUTYRATE (C)

(7) WHITE SOFT
PARAFFIN (C)

(8) BETAMETHASONE
BUTYRATE PROPIONATE
(C)

(9) LORATADINE (C)

(10) GUAIAZULENE (C)

(11) DICLOFENAC
SODIUM (C)

(12) HEPARINOID (C)

(13)
TRICHLORMETHIAZIDE
(C)

(14) NIFEDIPINE (C)

(15) MAGNESIUM OXIDE
(C)

(16) PREDNISOLONE (T)

(17) PIPERACILLIN
SODIUM\TAZOBACTAM

AER No
Age in Years
Sex
Country
Primary Source
Reporter Type
Event Preferred Term of
Interest*
Severity Grade
Time to Onset (in
days)
Drug type (All)
Action Taken
Dechallenge
Rechallenge
Event Outcome
SODIUM (T)

(18) CEFEPIME (T)
2973364
57
Male
ITALY
Non-Interventional
Study/Program
Healthcare Professional
Infected skin ulcer
NR
NR
(1) PRALSETINIB (S)
NR
Unknown
N/A
Not Reported
3018332
```